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Abstract 
This thesis aimed to characterize Western Canadian “Brachyspira hampsonii” clinical 
isolates and to develop and characterize an attenuated “B. hampsonii” vaccine candidate. 
Clinical “B. hampsonii” isolates selected from different Western Canadian barns were 
described biochemically and by sequencing the NADH-oxidase (nox) gene to improve the 
information available about clinical isolates present in Western Canada. The biochemical profiles 
of two clade I and eight clade II isolates were compared and variability in some diagnostic 
biochemical markers (β-glucosidase and hippurate hydrolysis) was detected. Representative 
isolates of clade I and II “B. hampsonii” were also compared to other swine-associated Brachyspira 
spp. based on biochemical profiles and morphometric data. Cell dimensions, number of flagella, 
and select biochemical markers (hippurate hydrolysis, α-glucosidase, and β-glucosidase) were not 
sufficient to discern “B. hampsonii” from other Brachyspira species. The data highlighted that 
consistent biochemical characteristics (indole and α-galactosidase negative) of “B. hampsonii” and 
morphology were not sufficient to differentiate them from other Brachyspira spp. and that nox 
gene sequencing is a more reliable tool for identification and differentiation of Brachyspira 
species. 
Development of a potential vaccine strain was also carried out by serial passage of a 
virulent “B. hampsonii” clade II strain (passage 13 (P13)) for 100 passages, resulting in strain 
P113. The virulent P13 and serially passaged P113 strains were phenotypically and genotypically 
compared to identify any changes in P113. Phenotypes of P13 and P113, including the biochemical 
profile, β-haemolysis, growth profile, and virulence in a murine model, were compared to identify 
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changes. More extensive β-haemolysis and more rapid growth of P113 over P13 was observed 
suggesting laboratory adaptation after serial passage. Two experiments were performed to assess 
the virulence of P113 and P13 in a murine model, which both demonstrated a decrease of P113 
virulence, suggesting that partial attenuation was achieved. No difference between the virulent and 
attenuated strains was detected based on genomic profiling by random amplified polymorphic 
DNA (RAPD) or whole genome sequence comparison. 
The results of this thesis demonstrate the complexity of phenotypic identification and 
discrimination of “B. hampsonii” and other swine-associated Brachyspira species. Serial passage 
of a virulent “B. hampsonii” resulted in a laboratory adapted, partially attenuated strain that will 
be attenuated further and used as a potential vaccine. This serially passaged strain also provides 
opportunities for further studies to identify virulence determinants, which can aid immensely with 
prevention and treatment of “B. hampsonii”. 
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1 Introduction and Literature review 
1.1 Swine-associated Brachyspira  
The genus Brachyspira consists of Gram-negative, aerotolerant, motile, and β-haemolytic 
spirochaetes. The progress of the formation of the genus originated with Treponema, then Serpula, 
Serpulina, and Brachyspira (combination of existing Serpulina and Brachyspira genera) (Harris 
et al., 1972, Stanton et al., 1991, Stanton, 1992, Ochiai et al., 1997). Culture of Brachyspira spp. 
is performed anaerobically on variants of blood agar and in broth supplemented with fetal bovine 
serum or with fetal bovine serum and sheep blood (Joens and Kinyon, 1982, Jenkinson and Wingar, 
1981, Kunkle and Kinyon, 1988). Electron microscopy of several Brachyspira spp. revealed cells 
5 to 9.78 μm long and 0.27 to 0.36 μm wide with 8-16 periplasmic flagella per cell (Harris and 
Kinyon, 1972, Trott et al., 1996c, Stanton et al., 1997, Oxberry et al., 1998, Fellström et al., 1999, 
Mushtaq et al., 2015). Brachyspira spp. with standing in nomenclature and that are pathogenic in 
swine are B. hyodysenteriae, B. pilosicoli, and B. murdochii. “B. suanatina” is a proposed 
Brachyspira species that has only been found in parts of northern Europe where it has been isolated 
from pigs in Sweden and Denmark and mallards in Sweden (Råsbäck et al., 2006, Råsbäck et al., 
2007a, Mushtaq et al., 2015). Conventional pigs experimentally infected with a clinical isolate of 
“B. suanatina” from pigs or isolated from mallards led to dysentery-like signs and mild diarrhea, 
respectively (Råsbäck et al., 2007a, Mushtaq et al., 2015). Another pathogenic Brachyspira, for 
which the name “B. hampsonii” has been proposed is described in detail in section 1.1.2.. B. 
innocens and B. intermedia are non-pathogenic species that are also found in swine. 
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Brachyspira hyodysenteriae is the causative agent of swine dysentery and was the first 
characterized species of the genus, isolated from swine in 1972 (Harris et al., 1972). B. 
hyodysenteriae is strongly β-haemolytic, has 8 to 12 total periplasmic flagella, and is the most 
studied of the swine-pathogenic Brachyspira spp. (Trott et al., 1996c). The history of B. 
hyodysenteriae is discussed in more detail below.  
Milder disease (porcine intestinal colitis) is caused by B. pilosicoli, which can also cause 
intestinal colitis in humans, intestinal spirochaetosis in chickens, chronic diarrhea in weanling 
horses, and colonization of the intestines of dogs (Trott et al., 1996c, Fellström et al., 2001, 
Oxberry and Hampson, 2003, Hampson et al., 2006, Bait-Merabet et al., 2008). B. pilosicoli is 
weakly β-haemolytic, has 8 to 12 total periplasmic flagella, and was formerly known as “Anguilina 
coli”, then Serpulina pilosicoli (Lee and Hampson, 1994). B. pilosicoli is associated with diarrhea 
in humans in developing nations and, in some rare cases, spirochaetemia (spirochaete invasion of 
the bloodstream) in immunocompromised patients, which is of great concern due to the potential 
zoonosis of B. pilosicoli (Mikosza and Hampson, 2001, Bait-Merabet et al., 2008). In swine, B. 
pilosicoli infects the mucosal surface of the colonic epithelium, forming a dense layer of 
spirochaetes observed as a “false brush border” when viewed under microscopy (Trott et al., 
1996c). The colons of swine infected with B. pilosicoli exhibit gross lesions and watery, mucoid 
contents (Trott et al., 1996b). 
B. murdochii, a weakly β-haemolytic spirochaete, was originally considered to be non-
pathogenic but has been reported as an agent of catarrhal colitis (Jensen et al., 2010). While disease 
linked to B. murdochii has also been proposed to be due to high spirochaetal load (Weissenböck 
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et al., 2005, Komarek et al., 2009). B. murdochii, on multiple occasions, has been the most 
prevalent Brachyspira spp. recovered from swine with diarrhea in Spain and Portugal (Osorio et 
al., 2013) and in the USA (Warneke et al., 2014). A study of Brachyspira spp. colonizing healthy 
pigs on a farm with a history of Brachyspira diarrhea based on culture and identification by partial 
NADH-oxidase (nox) gene sequencing, revealed a high prevalence of B. murdochii-like isolates 
(Patterson et al., 2013). Among the isolates characterized in this study were strongly β-haemolytic 
Brachyspira highly similar to B. murdochii based on nox sequence, which suggests that there is 
variance in the haemolysis trait within B. murdochii (Patterson et al., 2013). 
Traditionally B. innocens is not thought to cause disease in pigs, but is able to colonize the 
colon of pigs (Kinyon and Harris, 1979). However, experimental colonization of gnotobiotic and 
conventional pigs with B. innocens led to mucoid faeces and typhlocolitis (inflammation of the 
colon and caecum) in the gnotobiotic pigs, but not conventional pigs, which suggests that B. 
innocens may have the potential to cause disease under certain conditions (Neef et al., 1994).  
Phylogenetic analysis of the genus has demonstrated that there is great diversity within the 
genus and even within species, and that distinct Brachyspira-like taxa with no obvious species 
affiliation can be isolated routinely from pigs (Råsbäck et al., 2007b, Backhans et al., 2010). Partial 
nox-sequencing of isolates cultured from a farrow-to-finish farm in western Canada indicated that 
a mixture of Brachyspira spp. were present at each production stage with more B. murdochii and 
unidentified Brachyspira taxa detected than other species (Patterson et al., 2013). The presence of 
species mixtures in individual animals and the enormous diversity of Brachyspira are added 
challenges for understanding Brachyspira spp. disease in pigs. Weissenböck et al. (2005) 
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postulated that the spirochaete load is a key factor in the production of disease in pigs, regardless 
of the Brachyspira spp. present within the colon, supporting the idea that Brachyspira disease is 
not solely due to a single Brachyspira species. The potential importance of Brachyspira 
communities is also illustrated by an investigation of pigs from herds with chronic health problems 
including wasting and diarrhea where Brachyspira detection was common (13% of 202 animals 
tested) and 37% of Brachyspira infected pigs were colonized by two or more Brachyspira spp. 
(Komarek et al., 2009). 
 
1.1.1  Brachyspira hyodysenteriae and swine dysentery 
Swine dysentery (mucohaemorrhagic diarrhea) was first described in 1921 and the 
aetiologic agent was subsequently identified in 1972 by electron microscopy to be a spirochaete 
and named Treponema hyodysenteriae (Harris and Kinyon, 1972, Harris et al., 1972). In 1972, 
Harris and Glock (1972) showed that experimental infection with T. hyodysenteriae leads to swine 
dysentery in conventional swine. In the years following its initial isolation and characterization, T. 
hyodysenteriae was assigned to the genus Serpula, then Serpulina, and finally Brachyspira 
(Stanton et al., 1991, Stanton, 1992, Ochiai et al., 1997). 
High morbidity and lower mortality of approximately 90% and 30%, respectively, have 
been reported for on-farm outbreaks of B. hyodysenteriae (Harris and Glock, 1973). The impact 
of swine-associated Brachyspira disease leads to poor feed conversion and growth rates, which 
negatively affects the economic return from the herd. Another problematic aspect of the disease is 
the cyclical pattern of disease where disease re-emerges in herds that have undergone treatment, 
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or affects replacement animals after depopulation of infected barns (Harris et al., 1999). Prevention 
of recurrence and eradication of Brachyspira spp. from affected farms is also complicated by the 
fact that the agent survives in animal and environmental reservoirs including feral pigs, mice, 
waterfowl, soil, water, and faeces (Joens and Kinyon, 1982, Boye et al., 1998, Oxberry et al., 1998, 
Phillips et al., 2009, Desrosiers, 2011, Martínez-Lobo et al., 2013, Rubin et al., 2013b). 
Subclinically infected pigs are another potential source of future outbreaks (Duff et al., 2014). 
 In infected animals, spirochetes are found in close proximity to the luminal surface of the 
colon and within colonic crypts (Glock et al., 1974). Putative virulence factors identified to date 
include haemolysis, cytolysis, motility, and endotoxins (Nibbelink and Wannemuehler, 1991, 
Muir et al., 1992, Milner and Sellwood, 1994). However, specific genetic determinants and 
mechanisms for these putative virulence factors have not been elucidated. Complicating the 
understanding of B. hyodysenteriae virulence is that swine dysentery is a multi-factorial disease, 
requiring environmental stressors such as cold temperatures, transportation stress, poor hygiene, 
and overstocking (Brandenburg et al., 1977, Burrough, 2016). It has also been suggested that 
availability of excess fermentable substrates in the diet reaching the colon can contribute to the 
expression of dysentery (Pluske et al., 1996). Further support for the multi-factorial nature of swine 
dysentery is found in the results of studies demonstrating that singular infection of gnotobiotic pigs 
with B. hyodysenteriae does not lead to dysentery, but co-infection with other anaerobic bacteria 
does (Meyer et al., 1975, Brandenburg et al., 1977). 
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1.1.2 Re-emergence of mucohaemorrhagic diarrhea in Western Canada 
A re-emergence of mucohaemorrhagic diarrhea and colitis was noted by producers and 
veterinarians in North America beginning in 2007 (Harding et al., 2010, Burrough et al., 2012b, 
Hampson et al., 2015). The rise of antibiotic resistance has been suggested as a component of the 
re-emergence of mucohaemorrhagic diarrhea, with greater Brachyspira survival after antibiotic 
treatment (Hidalgo et al., 2011, Rugna et al., 2015). Subclinical disease may have also permitted 
persistent infections that led to outbreaks due to changes in the environmental conditions 
(temperature stress, poor hygiene, crowding, transportation), diet (type of carbohydrate, 
concentration of feed additives), or spirochaete load (O' Connor et al., 1979, Pluske et al., 1998, 
Durmic et al., 2002, Weissenböck et al., 2005, Hansen et al., 2011, Hampson et al., 2015, 
Burrough, 2016). The cessation of use of specific antimicrobials such as carbadox (sale stoppage 
in Canada in 2001) may also be linked to the re-emergence of mucohaemorrhagic diarrhea due to 
Brachyspira spp. (Hampson et al., 2015). Reservoirs of Brachyspira spp. in feral pigs, mice, 
waterfowl, soil, and water may have also provided Brachyspira protection against eradication and 
enabled unknown changes to occur in these reservoirs in the spirochaetes that contributed to the 
re-emergence (Joens and Kinyon, 1982, Boye et al., 1998, Oxberry et al., 1998, Phillips et al., 
2009, Desrosiers, 2011, Martínez-Lobo et al., 2013, Rubin et al., 2013b). The re-emergence of 
mucohaemorrhagic diarrhea has been multi-faceted and complex, adding to the challenge of 
understanding Brachyspira-associated disease. Another major contributor to resurgence of 
mucohaemorrhagic diarrhea as a production-limiting disease has been the emergence of at least 
one new species of Brachyspira. 
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The agent responsible for the re-emergence of dysentery-like disease in North America, 
was identified in clinical material using NADH-oxidase (nox) gene sequencing (Harding et al., 
2010). Sequences of partial nox gene PCR amplicons from these cases were found to be only 92% 
identical to any known Brachyspira sp. (Harding et al., 2010). Results of case-control studies 
supported a strong association between detection of this nox sequence and mucohaemorrhagic 
diarrhea in pigs free of B. hyodysenteriae, B. pilosicoli, and Lawsonia intracellularis (Harding et 
al., 2012). Further investigation revealed two separate clades (clades I and II) within the novel 
species that could be resolved through nox and 16S rRNA gene sequencing (Chander et al., 2012) 
and it was established that like B. hyodysenteriae, the new spirochete was strongly β-haemolytic. 
The name “B. hampsonii” has been proposed for this novel species (Chander et al., 2012, Mirajkar 
et al., 2016). 
Burrough et al. (2012b) demonstrated that “B. hampsonii” fulfilled Koch’s postulates when 
conventional pigs inoculated with clinical isolates of “B. hampsonii” developed 
mucohaemorrhagic diarrhea and spirochaetes from infected animals were isolated and identified 
to be “B. hampsonii”. Subsequent experimental inoculations of conventional pigs with either tissue 
homogenate or a clinical isolate of clade II “B. hampsonii” (D09-30446) produced 
mucohaemorrhagic diarrhea and “B. hampsonii” D09-30446 was recovered from these 
experimentally inoculated pigs (Rubin et al., 2013a). Similar experiments established the 
pathogenicity of “B. hampsonii” clade I (Burrough et al., 2012b, Costa et al., 2014b). The clinical 
and pathological presentation of disease following infection with either clade I or clade II “B. 
hampsonii” was indistinguishable from swine dysentery.  
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1.1.2.1 Global “B. hampsonii” distribution 
The distribution of “B. hampsonii” is challenging to describe due to the many reservoirs 
(feral pigs, mice, waterfowl, soil, water, and fomites) and methods of transport (migrating 
waterfowl and pig transport) that have been identified. However, based on investigations to date, 
“B. hampsonii” is widely distributed across North America and has also been detected in Europe 
(Phillips et al., 2007, Chander et al., 2012, Martínez-Lobo et al., 2013, Rubin et al., 2013a, Rubin 
et al., 2013b, Rohde et al., 2014, Mirajkar et al., 2015). Detection of “B. hampsonii” from Czech 
pigs in Belgium and Belgian pigs in Germany highlights that transport of pigs plays a potentially 
significant role in widening the distribution of the spirochaetes among farms (Mahu et al., 2014, 
Rohde et al., 2014). “B. hampsonii” has been detected in three species of waterfowl to date: lesser 
snow geese, greylag geese, and mallards (Martínez-Lobo et al., 2013, Rubin et al., 2013b). It is 
very likely that the distribution of “B. hampsonii” and other Brachyspira spp. is wider than 
currently acknowledged but information is lacking. Knowledge of distribution of Brachyspira spp. 
has been primarily through passive surveillance (voluntary reporting and diagnostic sample 
submission by producers and veterinarians), so its true prevalence remains unknown (Hampson et 
al., 2015). 
In North America, a difference in clade distribution has been noted for unknown reasons, 
with more clade I “B. hampsonii” detected in the United States of America and more clade II “B. 
hampsonii” in Western Canada (Mirajkar et al., 2015, Perez et al., 2016). In Europe, clade I “B. 
hampsonii” has been detected in pigs in Belgium and Germany, while the clade affiliation of 
isolates from waterfowl in Spain has not been specified (Mahu et al., 2014, Rohde et al., 2014, 
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Martínez-Lobo et al., 2013). One particular isolate (P280/1) from the United Kingdom in the 1990s 
was labelled at the time as a non-B. hyodysenteriae strain, but was recently suggested to belong to 
“B. hampsonii” (Neef et al., 1994, Mirajkar et al., 2015). A recent retrospective study of clinical 
submissions in western Canada showed that the earliest cases of “B. hampsonii” clade I and II in 
western Canada were 2002 and 2006, respectively, and each involved a single farm (Fernando et 
al., unpublished). More information on the distribution of “B. hampsonii” is needed to improve 
diagnosis and ensure that appropriate tools are available and utilized to control future outbreaks. 
 
1.1.2.2 Diagnostics of clinical material and tools for Brachyspira detection and identification 
Identification of the cause of mucohaemorrhagic diarrhea and other Brachyspira-related 
disease is important for appropriate treatment of herds. Diagnosis may be performed based on 
some combination of clinical signs, gross and histopathology, microscopic detection of 
spirochaetes, culture of spirochaetes from faeces or colonic tissue and differentiation of strength 
of β-haemolysis (Burrough, 2016). Histology has been useful for the detection of spirochaetes and 
determining their location within tissues after necropsy of pigs with disease, while lesions found 
during necropsy provides more information about the degree of illness and progress of disease 
(Hughes et al., 1977, Kinyon et al., 1977). Advances in laboratory detection and identification of 
Brachyspira have been made with the addition of biochemical assays, genome profiling tools, 
polymerase chain reaction (PCR), quantitative PCR, matrix-assisted laser desorption/ionization 
time-of-flight (MALDI-TOF) mass spectrometry, enzyme-immunoabsorbent assays (ELISA), and 
fluorescence in situ hybridization (FISH). Routine detection of “B. hampsonii” and other 
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Brachyspira spp. has shifted towards the use of tools such as PCR and MALDI-TOF, which 
provide differentiation capabilities that bolster traditional diagnostic methods (Burrough, 2016). 
Microscopy has been useful for identifying isolated spirochaetes, although it is not useful 
for differentiating Brachyspira species due to similar sizes and morphologies (Hughes et al., 1977, 
Perez et al., 2016). Haemolysis strength is a characteristic used for differentiating cultured 
Brachyspira spp. from samples, as strong β-haemolysis suggests that an isolate may be B. 
hyodysenteriae, “B. hampsonii”, or “B. suanatina” (Chander et al., 2012, Råsbäck et al., 2007a). 
However, variation in strength β-haemolysis has been observed among isolates of B. 
hyodysenteriae and B. pilosicoli, making haemolysis strength a less reliable option for 
classification of Brachyspira spp. as “strongly” or “weakly” β-haemolytic (Mahu et al., 2016). 
Biochemical characterization and multi-locus sequence typing (MLST) have been used to 
characterize “B. hampsonii” isolates further and, in some cases, improve differentiation of strains, 
but are not used as the primary tools for detection and identification of “B. hampsonii” (Chander 
et al., 2012). MLST has proven useful for investigations aimed at elucidating global distribution 
and population structure of “B. hampsonii” (Mirajkar et al., 2015). 
The NADH-oxidase (nox) gene is the preferred genetic marker for Brachyspira compared 
to the 16S rRNA gene as phylogenetic analysis with the nox gene sequence provides greater 
discrimination of Brachyspira spp. (Chander et al., 2012). Genus-specific PCR primers facilitate 
the amplification of nox sequences from any Brachyspira spp. (Atyeo et al., 1999), and so nox 
PCR followed by sequencing has become a mainstay in diagnostic laboratories. Various species-
specific PCR, real-time quantitative PCR assays and restriction fragment length polymorphism 
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(RFLP) approaches have been developed based on the nox gene sequence (Rohde et al., 2002, 
Song and Hampson, 2009, Rohde and Habighorst-Blome, 2012, Aller-Morán et al., 2016). 
MALDI-TOF generates spectra profiles for isolates that are compared to a reference 
database. While it has been shown to be effective for identification of Brachyspira species, it 
cannot reliably differentiate “B. hampsonii” clades (Calderaro et al., 2013, Warneke et al., 2014). 
The initial set-up costs for MALDI-TOF are also limiting, although analysis cost per sample once 
the equipment is in place is extremely low. 
Serological ELISA has been developed to detect serum antibodies against B. 
hyodysenteriae with high specificity and sensitivity (Song et al., 2015). ELISAs are useful for 
detecting pathogen exposure even in clinically healthy animals, but this method is not suited for 
detection of B. hyodysenteriae infection during an active outbreak since time is required for 
seropositivity to occur. Furthermore, “B. hampsonii” antigens still need to be identified in order to 
adapt the method for detection of serum response against “B. hampsonii”   (Hampson et al., 2016).  
Fluorescence in situ hybridization has also been utilized to specifically detect “B. 
hampsonii” or other Brachyspira spp. in histologic sections of formalin-fixed colonic tissue from 
infected pigs (Burrough et al., 2013), but this approach is also not practical for routine clinical 
diagnostics. 
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1.1.2.3 “B. hampsonii” in swine and virulence determinants 
In swine, “B. hampsonii” causes mucohaemorrhagic colitis and has been observed in the 
crypts of the colon of infected animals (Rubin et al., 2013a). The pathogenesis of Brachyspira 
including “B. hampsonii” is not yet well understood, as the determinants of virulence have not 
been elucidated. Some putative virulence determinants have been suggested for the genus, 
including haemolysis, motility, and lipopolysaccharides (Nuessen et al., 1982, Halter and Joens, 
1988, Greer and Wannemuehler, 1989, Bellgard et al., 2009, Naresh and Hampson, 2010).  
Haemolysis, as observed on agar containing blood, is suggestive of the capacity for 
cytotoxicity against enterocytes and other cell types (Muir et al., 1992), and several putative 
haemolysins have been identified (ter Huurne et al., 1994, Hsu et al., 2001, Wanchanthuek et al., 
2010). Strong β-haemolysis has been generally associated with greater virulence (Hyatt et al., 
1994), and indeed the species that cause most severe disease in pigs (B. hyodysenteriae, “B. 
hampsonii” and “B. suanatina”) are all defined as strongly haemolytic. However, identification of 
atypical isolates of B. hyodysenteriae and “B. hampsonii” with moderate or weak β-haemolysis 
has demonstrated that variance in the β-haemolysis trait exists and thus it may not always be 
reliable for indicating virulence of an isolate (Rubin et al., 2013b, Mahu et al., 2016).  
Snake-like motility driven by periplasmic flagella allows Brachyspira spp. to navigate 
through viscous material and mucus, while chemotaxis guides the spirochaete to colonize the 
surface or crypts of the swine colon (Kennedy et al., 1988). “B. hampsonii” have been observed 
in colonic crypts, where they are suspected to cause disease by some unknown mechanisms, and 
with snake-like motility under microscopy (Burrough et al., 2013, Rubin et al., 2013a). 
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Lipopolysaccharides are another group of virulence determinants that have been shown to 
be mostly homologously reactive with sera from rabbits exposed to whole cell extracts or pigs with 
swine dysentery due to B. hyodysenteriae, and some are toxic to mice and cultured murine cells 
(Nuessen et al., 1983, Halter and Joens, 1988, Greer and Wannemuehler, 1989). However, 
variation of lipopolysaccharides between serotypes and species may permit colonization and 
disease if Brachyspira immunity is induced only by highly-specific antigens (Halter and Joens, 
1988, Lee and Hampson, 1999, Hidalgo et al., 2010). Panels of lipooligosaccharides have also 
been useful for detecting B. hyodysenteriae in herds by ELISA, although lipooligosaccharides 
from sera from pigs exposed to other Brachyspira do not react with the antibodies (Joens et al., 
1982).  
In addition to specific features of Brachyspira pathogens, other extrinsic factors have been 
suggested to be important determinants of virulence of Brachyspira spp. in swine. Early 
experiments investigating Brachyspira pathogenesis showed that infection of gnotobiotic pigs with 
B. hyodysenteriae alone or co-infection with B. hyodysenteriae and Vibrio coli failed to cause 
disease (Brandenburg et al., 1977). The presence of other anaerobic bacteria was later suggested 
as an important factor in the virulence of certain Brachyspira spp., since B. hyodysenteriae co-
infection with select anaerobic bacteria led to disease in gnotobiotic pigs, which did not become 
ill after sole B. hyodysenteriae infection (Whipp et al., 1979). These observations suggest that at 
least some of the pathogenicity of Brachyspira is due to secondary infection once the integrity of 
the colon epithelium is compromised. The role of the resident intestinal microbiota in Brachyspira 
pathogenesis remains unclear, and preliminary investigations of the relationship of colon 
microbiota population structure to development of clinical disease in experimentally infected pigs 
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did not reveal any obvious determinants of susceptibility (Costa et al., 2014a). Others have 
suggested that the total spirochaete load within an animal is a possible determinant in the 
development of disease (Weissenböck et al., 2005). The detection of only “non-pathogenic” 
Brachyspira spp. (B. innocens, B. murdochii, and B. intermedia) in pigs diagnosed as swine 
dysentery cases raises the possibility that high spirochaete load regardless of species, may cause 
disease (Weissenböck et al., 2005). Although specific virulence factors are still not well 
understood due to the multi-factorial nature of Brachyspira-associated disease, progress is being 
made with advances in available tools and in vivo models to study disease. 
 
1.2 Brachyspira disease models 
Since “B. hampsonii” naturally infects and causes disease in swine, both conventional and 
gnotobiotic swine models are ideal models for studying its pathogenesis. Conventional pigs 
possess the wild-type gastrointestinal microbiota, whereas gnotobiotic pigs are germ-free. The 
models can be inoculated orally or less commonly via ligated colonic loops (Joens and Kinyon, 
1982). High health weaner pigs (aged 3 to 10 weeks old) are commonly used as animal models 
since pigs at this age are most vulnerable, although older pigs may still become infected (Kinyon 
et al., 1977, Hampson, 2012). Pigs with high health, being free of pathogens including Lawsonia 
intracellularis, porcine circovirus type 2 (PCV2) and porcine respiratory and reproductive 
syndrome virus (PRRSV), and with no history of swine dysentery, are required to avoid other 
illness and false positive results due to non-bloody diarrhea caused by L. intracellularis, PCV2, or 
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by other swine-virulent Brachyspira spp. (Møller et al., 1998, Pogranichniy et al., 2002, Segalés 
and Domingo, 2002, Rubin et al., 2013a).  
Diet fed to pigs during experimental inoculation experiments is another factor that affects 
disease development. A reduction in the expression of swine dysentery has been observed in pigs 
fed modified diets with cooked white rice or distillers dried grains with solubles (DGGS), while 
modified diets with soybean meal or resistant carbohydrates are associated with increases in swine 
dysentery expression (Siba et al., 1996, Pluske et al., 1998, Burrough, 2016). High levels of 
soybean meal have been suggested as necessary for the expression of clinical signs of swine 
dysentery, although other studies utilized commercial diets without soybean (Jacobson et al., 2004, 
Rubin et al., 2013b, Burrough, 2016). It has also been noted that other factors are important in the 
development of disease in the laboratory setting, such as cold ambient temperature, and inoculum 
dosage (Brandenburg and Wilson, 1974, Burrough, 2016).  
Outcomes of interest in animal inoculation studies are changes in weight gain, faecal 
consistency changes, faecal shedding of spirochaetes, lesions in the colon, and presence of 
spirochaetes in colonic crypts (Kinyon et al., 1977, Rubin et al., 2013a). Swine models have been 
valuable in providing a realistic presentation of the disease for study of pathogenesis and the 
possible preventative effect of certain diets and vaccines, but achieving adequate statistical power 
may require large numbers of animals, which presents logistical and animal welfare challenges 
(Jacobson et al., 2004, Burrough, 2016).  
A desire to reduce animal use and study cost, and improve statistical power led to the 
development of other models to study Brachyspira spp., such as in vitro organ culture (IVOC) and 
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mouse models (Joens and Glock, 1979, Costa et al., 2016b). Porcine IVOC has been developed to 
observe Brachyspira infection of and interaction with the colonic epithelium, but is limited as 
challenges with maintenance of viability of the IVOC requires experimental timelines of less than 
5 days  (Costa et al., 2016b, Costa et al., 2016a). Murine models have also been adapted for use in 
Brachyspira spp. infection studies due to the low cost of mice, ease of housing and care (Joens and 
Glock, 1979, Joens et al., 1980, Jamshidian et al., 2004). “B. hampsonii” has not been isolated 
from wild rodents yet, but other swine-pathogenic and non-pathogenic Brachyspira spp. have been 
isolated from wild rodents (Joens and Kinyon, 1982, Fellström et al., 2004, Backhans et al., 2010).  
Two murine models (CF1 and C3H strains) have been experimentally infected with B. 
hyodysenteriae and “B. hampsonii”, while C3H has also been used to model B. pilosicoli infection 
(Joens and Glock, 1979, Nibbelink and Wannemuehler, 1991, Jamshidian et al., 2004, Burrough 
et al., 2012a, Ek et al., Submitted). For both B. hyodysenteriae and B. pilosicoli infection models, 
special diets were required for colonization and expression of some disease signs (decreased 
weight, colonic lesions, luminal mucus, and shedding), but blood and diarrhea have not been 
observed in these models (Joens and Glock, 1979, Nibbelink and Wannemuehler, 1992, 
Jamshidian et al., 2004, Burrough et al., 2012a). Assessments of disease in both CF1 and C3H 
models have been limited to detection of shedding by culture and/or PCR of faeces, weight 
changes, and identification of gross and microscopic lesions (Joens and Glock, 1979, Jamshidian 
et al., 2004, Ek et al., Submitted). Clinical signs have been overlooked (or at least not reported) in 
most studies that have utilized murine models, but mucoid faeces have been observed in CF1 mice 
experimentally infected with B. hyodysenteriae (Joens and Glock, 1979). Recent studies focused 
on detecting spirochaete shedding, weight changes, and histology have preferred utilization of the 
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C3H mouse strain, but the reasons for using this strain as a model have not been explained 
(Burrough et al., 2012a). Regular commercial rodent diet and a low-zinc diet have been used for 
both murine model strains to enhance clinical signs due to Brachyspira hyodysenteriae infection 
(Joens and Glock, 1979, Suenaga and Yamazaki, 1984). A recent comparison of the regular 
commercial and low-zinc diets for mice experimentally infected with  B. hyodysenteriae or “B. 
hampsonii” demonstrated that the low-zinc diet enhances disease in both CF1 and C3H mouse 
strains (Ek et al., Submitted). However, clinical disease (occurrence of abnormal feces) was more 
evident in the CF1 mice, which suggests that it is a more sensitive model for demonstrating 
virulence of Brachyspira spp. (Ek et al., Submitted). Another important factor to produce 
colonization in CF1 and C3H mice are inocula with greater than 1×102 CFU/mL and 1×106 
CFU/mL, respectively (Suenaga and Yamazaki, 1984, Nibbelink and Wannemuehler, 1991).  
 
1.3 Disease intervention 
1.3.1 Current methods of prevention, treatment and control 
Prevention of Brachyspira infection is done through various enhancements to standard 
biosecurity methods, which help prevent infection of herds and barns with Brachyspira. Enhanced 
biosecurity consists of limiting traffic into the farm and through aggressive rodent control 
(Burrough, 2016). Limitations on visitors based on how recently they have visited another farm 
can help reduce the likelihood of transmission of Brachyspira or other pathogens. The shower-in-
shower-out practice can also help prevent introduction or export of pathogens via farm workers. 
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The removal of faecal matter by pressure washing, disinfection, and drying of vehicles can also 
help reduce the likelihood of transmission of Brachyspira and other pathogens in faeces in vehicles 
and trailers (Dewey et al., 2014). If preventative measures are not able to prevent exposure and 
infection, other practices must be implemented to manage the infection and disease. Monitoring is 
key to detecting diarrhea and quick identification of the cause of disease using submitted live pigs 
or tissue samples for PCR, microbiological culture, and histopathology (Harding et al., 2013, 
Burrough, 2016). Detection of “B. hampsonii” can then be followed up with treatment using 
antibiotics and enhancement of biosecurity to prevent future outbreaks. 
Brachyspira-infection on a farm is managed by use of in-feed/in-water antibiotics and all-
in-all-out herd movement. So far tiamulin has been shown to clear clinical signs within 24 hours 
and cease shedding of “B. hampsonii” after 72 hours using 0.006 and 0.018% (v/v) tiamulin in 
water (Wilberts et al., 2014). In-feed medication has also been used as a vehicle for antibiotics and 
continuous treatment with antibiotics has been demonstrated to suppress pathogenic Brachyspira 
spp. populations, and thus reduce the number of cases of swine dysentery (Hampson et al., 2015). 
The practice of all-in-all-out herd management can help prevent future outbreaks on the farm due 
to subclinically infected pigs mixed with replacement pigs by permitting a period of 
decontamination between herds, ensuring that the new incoming herds are not infected by pigs 
previously colonized by Brachyspira. All-in-all-out herds have been reported to perform better, 
with higher daily gain, lower mortality, and fewer cases of some illnesses (Heinonen et al., 2001). 
When management practices are not able to suppress pathogen levels and prevent outbreaks, 
treatment with antibiotics becomes necessary. 
19 
 
Treatment of pigs exhibiting mucohaemorrhagic diarrhea is performed using antibiotics 
including pleuromutilins, lincosamides, macrolides, quinoxalines, and tetracyclines (Mirajkar and 
Gebhart, 2016). Tiamulin and valnemulin are most commonly used to treat swine dysentery due 
to B. hyodysenteriae and are also used to treat “B. hampsonii” infections (Wilberts et al., 2014, 
Burrough, 2016). However, issues with antibiotic resistance have arisen due to overuse (Hampson 
et al., 1993, Burch, 2005). Other challenges have been revealed through research on Brachyspira, 
such as the identification of prophage-like gene transfer agents that are transferred between B. 
hyodysenteriae strains when exposed to sub-inhibitory concentrations of carbadox and 
metronidazole (Stanton et al., 2008). These gene transfer agents contain 7.5 kb DNA that could 
contain antibiotic resistance genes conferring resistance to tylosin and chloramphenicol (Stanton 
et al., 2008). Resistance to macrolides and lincosamides is common, however tiamulin and 
valnemulin resistance has also observed in isolates from Germany (Rohde et al., 2004, Aarestrup 
et al., 2008).  
Additional management practices for preventing recurrent disease, such as 
decontamination and depopulation, are employed to prevent future infection of new naïve herds. 
Decontamination of infected barns is challenging given the ability of Brachyspira to survive in 
feces, requiring pressure washing, disinfection, drying, repair of surfaces, movement of faeces to 
a different location, and treatment of manure with lime (Fossi et al., 2001). The method of 
depopulation involves the removal of infected pigs, disinfection and cleaning of barns, followed 
by a period without pigs in the barns, then addition of new healthy pigs. Even partial depopulation 
has been shown to be effective in treating infected pigs and preventing recurrence, although it is 
costly to implement (Figi et al., 2014). In addition to depopulation, movement of herds treated 
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with antibiotics to a clean barn has also been shown to prevent future outbreaks in the herd 
(Burrough, 2016). 
Stringent biosecurity procedures and thorough disinfection of previously infected barns 
can help prevent future “B. hampsonii” outbreaks (Burrough, 2016). However, eradication is 
difficult due to the different reservoirs that exist around barns including clinical sign-free but 
colonized pigs (Diego et al., 1995, Rubin et al., 2013b). Vaccines are not yet available against “B. 
hampsonii”, but would be a useful tool for aiding with control and eradication of the pathogen.  
 
1.3.2 Potential for a vaccine 
Vaccination against “B. hampsonii” has not been reported, while vaccination against B. 
hyodysenteriae has been attempted but has not been completely successful (Joens et al., 1983, 
Hampson et al., 1993). Cross-protection between serotypes of B. hyodysenteriae in swine was not 
observed when groups of swine were inoculated with different B. hyodysenteriae serotypes and 
followed by challenge with the same or different serotype by Joens et al. (1983), with protection 
only possible when re-infected with the same strain. Protection of 75-83% of pigs vaccinated 
against the same serotype of B. hyodysenteriae using an adjuvanted whole cell vaccine has been 
achieved, but protection against multiple serotypes still needs to be achieved to prevent disease at 
the herd level (Hampson et al., 1993). B. hyodysenteriae vaccination has also been performed 
using recombinant proteins, such as B. hyodysenteriae outer membrane protein BmpB that induced 
protection against B. hyodysenteriae in some immunized pigs (La et al., 2004, Witchell et al., 
2011). BmpB recombinant vaccines have been shown to reduce lesion formation, spirochaete 
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shedding, and appearance of clinical swine dysentery (La et al., 2004). The Vsp outer membrane 
proteins of B. hyodysenteriae have also been shown to be antigenic, but vaccination using these 
proteins requires multiple Vsp variants to induce a sufficient level of immune response in pigs 
against B. hyodysenteriae as Witchell et al. (2011) has shown. Smp proteins are another family of 
outer membrane protein with some sequence similarity to Bmp proteins, which have been 
evaluated as candidates for vaccine development (Holden et al., 2008). Experimental vaccination 
of mice with recombinant SmpB has led to 50% protection against B. hyodysenteriae (Holden et 
al., 2008). However, variation in the expression of the Smp family of outer membrane proteins has 
been identified among global isolates of B. hyodysenteriae, with either SmpA or SmpB expressed 
in USA isolates of B. hyodysenteriae while only SmpA expression has been detected in Spanish 
isolates of B. hyodysenteriae (Holden et al., 2006, Hidalgo et al., 2010).  
Progress on vaccine development and antigen research for the “B. hampsonii” has not yet 
advanced to the current state of B. hyodysenteriae research. Vaccine development for “B. 
hampsonii” is challenging since the species is quite distinct from B. hyodysenteriae and no specific 
antigenic epitopes have been identified for “B. hampsonii”. A possible vaccine development 
strategy achievable for “B. hampsonii” is production of a live attenuated strain through serial 
passage of a virulent strain in the laboratory, which would not require knowledge of the specific 
determinants of virulence. Evidence from previous pathogenicity trials with B. hyodysenteriae 
highlighted that a serially in vitro passaged (35 times) B. hyodysenteriae strain B78 (ATCC 27164) 
was no longer able to cause disease, supporting the idea that serial passage can also lead to 
attenuation of “B. hampsonii” (Kinyon et al., 1977).  
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Experience to date with Brachyspira spp. vaccine development suggests that identification 
of antigenic proteins and development of recombinant proteins for “B. hampsonii” may be 
challenging, especially given the lack of knowledge of infection mechanisms. However, based on 
previous work with B. hyodysenteriae, in vitro passaging of “B. hampsonii” to produce a live 
attenuated vaccine strain may present a viable alternative approach.  
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Objectives 
The re-emergence of mucohaemorrhagic diarrhea as a production limiting disease of pigs presents 
a significant challenge to swine producers. Control and eradication of disease associated with “B. 
hampsonii” depends upon an improved understanding of pathogen biology and the development 
of tools for diagnosis, treatment and prevention of infection. To move toward achievement of these 
goals, the following objectives were addressed in this thesis:  
1. To further characterize the phenotypic and genotypic traits of Western Canadian clinical 
isolates of “B. hampsonii”. 
2. To produce an attenuated strain of “B. hampsonii” by serial passage in laboratory culture. 
  
24 
 
2 Characterization of “Brachyspira hampsonii” clades I and II 
isolated from commercial swine in Western Canada 
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2.1 Abstract 
Since 2009, a novel Brachyspira has emerged as a production limiting pathogen of pigs in North 
America. The name “Brachyspira hampsonii” has been proposed for this novel taxon. “B. 
hampsonii” is divided into two phylogenetically distinct clades based on sequence of the NADH 
oxidase gene, although the clinical disease associated with clades I and II is indistinguishable and 
phenotypic characteristics that discriminate the clades have not been determined. The objectives 
of the current study were to enhance the description of the provisional species “B. hampsonii” with 
biochemical profiles and morphometric data from isolates affecting Canadian swine, and to 
investigate potentially diagnostically informative characteristics for this emerging pathogen. 
Biochemical profiles of isolates from different commercial swine barns in Western Canada showed 
that biochemical profiles were insufficient to distinguish “B. hampsonii” clades I and II from each 
other or from other pathogenic Brachyspira. Hippurate hydrolysis, previously reported as 
uniformly negative in “B. hampsonii” was variable among Canadian isolates. Spirochete 
dimensions and flagella numbers for “B. hampsonii” overlapped with other Brachyspira species. 
Taken together, these results indicate that NADH oxidase gene sequencing remains a preferred 
method for identification and discrimination of “B. hampsonii” from other pig-associated 
Brachyspira spp. 
Key words: “Brachyspira hampsonii”, transmission electron microscopy, NADH oxidase, indole, 
hippurate 
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2.2 Introduction 
The genus Brachyspira consists of Gram negative, motile, β-haemolytic, aerotolerant 
spirochaetes infecting the gastrointestinal tracts of wild and domestic animals, as well as humans. 
In swine, Brachyspira hyodysenteriae is the causative agent of swine dysentery (Harris et al., 
1972), while B. pilosicoli infection is associated with spirochaetal colitis (Trott et al., 1996a). “B. 
suanatina”, originally isolated from mallard ducks, has also been shown to cause dysentery-like 
disease in experimentally inoculated pigs (Råsbäck et al., 2007a). Other species detected in pigs 
(B. intermedia, B. innocens, B. murdochii) are non-pathogenic or have been reported to cause mild 
catarrhal colitis under experimental conditions (Jensen et al., 2010, Stanton et al., 1997). Re-
emergence of Brachyspira-associated mucohaemorrhagic diarrhea in swine in Western Canada 
and the US has been associated with a novel taxon (Harding et al., 2010), provisionally named 
“Brachyspira hampsonii” (Chander et al., 2012). “B. hampsonii” has also recently been detected 
in birds in Spain, in pigs in the Czech Republic and in pigs from Belgium transported to Germany 
(Martínez-Lobo et al., 2013, Mahu et al., 2014, Rohde et al., 2014). Phylogenetic analysis of the 
NADH-oxidase (nox), 16S rRNA, and 23S rRNA genes revealed two distinct clades within the 
taxon (Chander et al., 2012, Rubin et al., 2013b, Burrough et al., 2013). Replacement of clades I 
and II with genetic groups 1 to 4 has also been suggested based on multi-locus sequence typing of 
six targets for “B. hampsonii” (Mirajkar et al., 2015). Although the clinical disease associated with 
clades I and II is indistinguishable (Costa et al., 2014b, Rubin et al., 2013a), the phenotypic 
properties distinguishing them have not been established. 
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  Brachyspira do not form visible colonies on agar, so growth is detected on media 
containing blood by observing zones of β-haemolysis. Phenotypic characterization of Brachyspira 
is generally based on the evaluation of the strength of β-haemolysis on blood agar and activity of 
select biochemical markers (hippurate hydrolysis, indole production, α-galactosidase, α-
glucosidase, and β-glucosidase). Spirochaete size and number of periplasmic flagella can also be 
used to discriminate species, although these approaches are not practical for the diagnostic 
laboratory. The phenotypic and genotypic characteristics of “B. hampsonii” isolates in the USA 
have been described (Chander et al., 2012, Mirajkar et al., 2015). Here, we describe phenotypic 
characteristics of “B. hampsonii” clade I and II isolates collected from clinical cases of 
mucohaemorrhagic diarrhea in Western Canadian swine between 2009 and 2013. The objectives 
of this study were to enhance the description of the provisional species “B. hampsonii” with 
information from isolates affecting Canadian swine, and to investigate potentially diagnostically 
informative characteristics for this emerging pathogen. 
 
2.3 Materials and Methods 
2.3.1 Selection of clinical isolates 
  “B. hampsonii” clade I isolate D11-30599 and clade II isolate D09-30446 were the first 
Canadian isolates of each clade derived from clinical cases of mucohaemorrhagic diarrhea in 2011 
and 2009, respectively. The other isolates included in the study (one additional clade I and 7 
additional clade II) were selected from a collection of isolates from 443 “B. hampsonii”-confirmed 
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clinical cases from different swine production sites in Alberta, Manitoba, or Saskatchewan 
between 2009 and 2013. The original identification of the isolates from these clinical cases was 
done using culture, nox sequencing, and clade-specific PCR with previously described assays 
(Costa et al., 2014b, Rubin et al., 2013a). While a number of clade I and II isolates were obtained 
from farms during this time period, isolates were selected for the current study only if they 
originated from different production systems (i.e. were epidemiologically distinct). Long-term 
storage of Brachyspira isolates from clinical cases was at -80°C in brain-heart infusion (BHI) broth 
containing 10% (v/v) glycerol.  
2.3.2 nox gene sequencing and phylogenetic analysis 
Genomic DNA was extracted and purified from JBS broth cultures (“Joe’s Brachyspira 
Sask30446 Broth” is brain heart infusion (BHI, Becton Dickinson Canada, Mississauga, ON) with 
1% (w/v) glucose, 5% (v/v) fetal bovine serum, 5% (v/v) sheep blood) using the DNeasy Blood & 
Tissue Kit (QIAGEN Inc., Mississauga, ON) following the manufacturer’s instructions for pre-
treatment for Gram negative bacteria and the Animal Tissue protocol. A 939 bp region of the nox 
gene was amplified using genus-specific primers Bnoxf (5’-TAG CYT GCG GTA TYG CWC 
TTT GG-3’) and Bnoxr (5’-CTT CAG ACC AYC CAG TAG AAG CC-3’) as previously 
described (Rubin et al., 2013a, Rohde et al., 2002). PCR products were purified using the EZ-10 
Spin Column PCR Products Purification Kit (Bio Basic Inc., Markham, ON) and sequenced with 
the amplification primers. Raw sequence data were trimmed to a uniform length of 810 bp prior to 
alignment with CLUSTALw and phylogenetic tree construction using PHYLIP (Felsenstein, 
1989).  
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2.3.3 Biochemical tests 
Study isolates were grown in BHIS (BHI with 1% (w/v) glucose, 10% (v/v) fetal bovine 
serum) broth to mid-log phase. Cultures were adjusted to McFarland 5 and enzymatic activities 
were determined using the API-zym kit (BioMerieux, St. Laurent, QC) according to the 
manufacturer’s instructions. Spot indole and hippurate broth assays were performed as previously 
described (Fellström and Gunnarsson, 1995). B. hyodysenteriae ATCC 27164T and B. pilosicoli 
ATCC 51139T were included as controls in all biochemical tests.  
2.3.4 Electron microscopy 
Log phase Brachyspira cultures were prepared for TEM using the single droplet negative 
staining technique and carbon coated 200 mesh-200G-CP grids (Stanton et al., 1998, Trott et al., 
1996a). Flagella counts, cell width (average of three locations along the length of the spirochaete 
not including the tapered region near both ends), and cell length were measured using ImagePro 
Plus (Media Cybernetics, Rockville, MD) on captured TEM images (Figure 2.2). Twenty cells of 
each isolate were measured. Images were considered suitable for width and length measurements 
if the cells were intact, isolated, and not twisted on themselves. Flagella counts were performed on 
untwisted cells with at least one end visible.  
2.4 Results and Discussion 
 Clinical isolates of “B. hampsonii” were selected to represent distinct pig 
production sites, although most were related by a common source of replacement females. The 
number of isolates included in the study from either clade (two clade I and eight clade II) reflects 
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higher isolation rates of clade II isolates from clinical samples submitted to our laboratory, which 
to our knowledge was the only laboratory performing clade level identification of “B. hampsonii” 
in Western Canada during the period of study. This trend in relative occurrence of clade I and II 
“B. hampsonii” is opposite to that reported in a recent study of “B. hampsonii” diversity in the 
United States (Mirajkar et al., 2015). Clade affiliation was confirmed, and relatedness of the 
selected clinical isolates to other Brachyspira species was investigated based on partial NADH 
oxidase (nox) gene sequences. The nox sequences of the two clade I isolates were identical, while 
the pairwise identities between clade II isolates ranged from 99-100% (Figure 2.1).   
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Figure 2.1. Phylogenetic relationships of “B. hampsonii” study isolates and reference species 
based on partial nox sequences. Bootstrap values (out of 1000) are indicated at the nodes. 
Reference sequences were included from B. aalborgi ATCC 43994T (GenBank accession No. 
AF060816), B. murdochii ATCC 51284T (KC984308), B. innocens ATCC 29796T (KC984307), 
B. pilosicoli ATCC 51139T (KC984310), B. intermedia ATCC 51140T (KC984309), “B. 
suanatina” AN 4859-03 (DQ487119), and B. hyodysenteriae ATCC 27164T (KC984311). Scale 
bar indicates 0.1 substitutions per site.  
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 Results of the API-zym, indole production and hippurate hydrolysis tests for study isolates 
are summarized in Table 1. Activities of α-galactosidase, α-glucosidase, and β-glucosidase, and 
indole production and hippurate hydrolysis have been utilized as biochemical markers for 
differentiation of Brachyspira species (Achacha and Messier, 1991, Fellström and Gunnarsson, 
1995). All clade I and II study isolates were negative for α-galactosidase activity, one clade II 
isolate was positive for α-glucosidase, and both clade I isolates and 6/8 clade II isolates were 
positive for β-glucosidase activity (Table 2.1). Although indole production was negative for all 
isolates as expected, hippurate hydrolysis activity was inconsistent among isolates in both clades 
(Table 2.1). These results are consistent with a previous phenotypic description of “B. hampsonii” 
from the USA (Chander et al., 2012) in that none of these assays could distinguish clade I and 
clade II isolates. Interestingly, all isolates in the USA study (n=17 clade I, n=3 clade II) were 
negative for hippurate hydrolysis activity (Chander et al., 2012). Variations in indole production, 
hippurate hydrolysis, α-galactosidase, and α-glucosidase activities of human isolates of B. 
pilosicoli have been previously observed (De Smet et al., 1998), and variation in indole production 
of swine-isolated B. hyodysenteriae has also been reported (Fellström et al., 1999). The greater 
consistency in hippurate hydrolysis activity in the USA study may reflect epidemiological 
relationships of isolates, but these relationships are not described in that report. Taken together, 
these results show that none of these biochemical assays can discriminate clade I and II or “B. 
hampsonii” from B. hyodysenteriae (Table 2.2). The lack of specificity of biochemical markers 
for differentiating Brachyspira species has inspired the development of MALDI-TOF (matrix-
assisted laser desorption/ionization time-of-flight) as a promising phenotypic method for 
differentiation of Brachyspira. This technology has been demonstrated to distinguish Brachyspira 
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species (Prohaska et al., 2014, Calderaro et al., 2013), but clades of “B. hampsonii” are not reliably 
distinguished (Warneke et al., 2014). The initial capital costs for diagnostic MALDI-TOF have 
also limited its widespread adoption.  
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Table 2.1. Biochemical test results for Western Canadian clinical “B. hampsonii” isolates.  
Clade# Isolate α-galactosidase α-glucosidase β-glucosidase 
Indole 
Production 
Hippurate 
Hydrolysis 
I D11-30599 – – + – – 
 D12-32613 – – + – + 
II D09-30446 – – + – – 
 D11-29565-A6P8 – – + – + 
 D12-09991-28 – – – – – 
 D12-10616-P8 – – + – + 
 D12-27447 – – Weak + – + 
 D12-27451 – – + – + 
 D12-32539 – – + – + 
 D13-06010 – + – – – 
#Based on partial nox gene sequence 
 
  
Table 2.2. Morphological and biochemical characteristics of “B. hampsonii” clade I and clade II and other swine-associated Brachyspira 
species. 
Characteristic 
"B. hampsonii" 
clade I 
"B. hampsonii" 
clade II 
B. hyodysenteriae  
(Trott et al., 
1996a) 
“B. suanatina” 
(Mushtaq et al., 
2015, Råsbäck 
et al., 2007a) 
B. pilosicoli  
(Trott et al., 
1996a) 
B. innocens 
(Oxberry et al., 
1998) 
B. murdochii  
(Jensen et al., 
2010, Stanton 
et al., 1997) 
B. intermedia  
(Stanton et 
al., 1997, 
Jensen et al., 
2010) 
Cell length (µm) 7.27 ± 1.30# 8.53 ± 2.19# 9.78 ± 1.87§ 7.27 ± 1.00$ 6.27 ± 0.98§ 9.40 ± 1.85§ 5-8* 7.5-10* 
Cell diameter (µm) 0.26 ± 0.045# 0.46 ± 0.05# 0.35 ± 0.02§ 0.3 ± 0.00$ 0.27 ± 0.03§ 0.36 ± 0.03§ 0.35-0.40* 0.35-0.45* 
No. flagella 11-16¶ 12-15¶ 8-12 14-16 4-6 10-13 11-13 12-14 
β-haemolysis Strong Strong Strong Strong Weak Weak Weak Weak 
Indole production – – + Weak + – – – + 
Hippurate hydrolysis Variable Variable – − + – – – 
α-galactosidase – – – − + + – – 
α-glucosidase – Variable + Weak + – – – + 
β-glucosidase + Variable + + – + – + 
# Mean ± standard deviation for 20 spirochaetes  
¶ Range for 15 spirochaetes 
§ Mean ± standard deviation for 5 spirochaetes 
*Authors reported range 
$ Mean ± standard deviation for 10+ spirochaetes 
 
3
5
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 Transmission electron microscopy was performed on D11-30599 and D09-30446 to 
measure the dimensions of the spirochaetes and count the number of flagella for comparison to 
other Brachyspira species. Representative images are shown in Fig 2. Spirochaetes of clade I “B. 
hampsonii” isolate D11-30599 were 7.27 ± 1.30 μm and 0.26 ± 0.045 μm, with 11-16 periplasmic 
flagella (Figure 2.2a, Figure 2.2b, Table 2.2). For clade II isolate D09-30446, average length and 
width were 8.53 ± 2.19 μm and 0.46 ± 0.05 μm, with 12-15 periplasmic flagella (Figure 2.2c, 
Figure 2.2d, Table 2.2). Apparently dividing cells were observed (Figure 2.2e), and tailed 
bacteriophages were occasionally detected on the surface D09-30446 spirochaetes under TEM 
(Figure 2.2f). The presence of tailed bacteriophages is consistent with the type of bacteriophage 
detected with other Brachyspira (Ackermann, 2007, Calderaro et al., 1998). The morphological 
measurements and flagella counts for “B. hampsonii” overlapped with other pig associated 
Brachyspira species and so do not on their own provide species identification (Table 2.2). 
  
37 
 
 
Figure 2.2. TEM images of clade I isolate D11-30599 (a, b) and clade II isolate D09-30446 (c, d, 
e, f). Images of entire spirochaete (a, c), periplasmic flagella (b, d), cell division (e), tip of D09-
30446 spirochaete with tailed bacteriophages (f). Scale bars represent 0.5 μm.  
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2.5 Conclusions 
 The biochemical variation of “B. hampsonii” isolates from Western Canadian swine 
production systems highlights that biochemical characterization alone is not diagnostically 
informative. Although some traits of “B. hampsonii” isolates are consistent (indole and α-
galactosidase negative), these characteristics are not solely sufficient to discern them from other 
Brachyspira species as previously observed in the USA study (Chander et al., 2012). The 
morphology of selected isolates was also indistinguishable from other species of Brachyspira. 
Based on these results and previous observations, nox gene sequencing remains a useful, accessible 
and affordable tool for identification and discrimination of Brachyspira spp. affecting pigs. 
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2.6 Transition Statement 
 The characterization of Western Canadian “B. hampsonii” isolates showed that phenotypic 
variation exists amongst clinical isolates. Due to this variation, the only reliable diagnostic 
phenotypes for discriminating “B. hampsonii” from other Brachyspira spp. profiles are the 
combination of indole production, α-glucosidase activity and β-haemolysis. However, these 
characteristics do not distinguish clade I and II “B. hampsonii”. Sequencing of the nox gene 
remains the best tool for identification and discrimination of different Brachyspira spp. and clades. 
The establishment of diagnostic characteristics for “B. hampsonii” is necessary to improve 
detection of the pathogen and to control the pathogen during outbreaks. Current methods for 
controlling infection are not effective due to the survival of Brachyspira spp. in the environment 
and wildlife. Depopulation, the removal of pigs from the barns and subsequent decontamination, 
is not sufficient in permanently removing the pathogen. Treatments against Brachyspira spp. are 
being challenged by the rising antibiotic resistance within the genus of Brachyspira. Better 
intervention methods, such as vaccination, are necessary for preventing future outbreaks, which 
may help with eradication of the pathogen from farms. Production of an attenuated vaccine strain, 
derived from a virulent strain can help control the pathogen and prevent future outbreaks of “B. 
hampsonii”. In addition to producing a strain for vaccine development, comparison of an 
attenuated strain with its virulent precursor may lead to the identification of virulence factors. 
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3.1 Abstract 
The re-emergence of mucohaemorrhagic diarrhea and the novel taxon “Brachyspira 
hampsonii” is a major concern of swine producers. Prevention is limited to improved biosecurity 
procedures, but better methods for disease prevention are required, such as herd vaccination. The 
objectives of the study were to develop and characterize a “B. hampsonii” vaccine strain. A virulent 
clade II “B. hampsonii” passage 13 (P13) strain was serially passaged to produce a passage 113 
(P113) strain that was phenotypically and genotypically characterized. The serially passaged strain 
was compared to the original virulent strain. No differences were identified in morphology or in 
selected biochemical markers of P13 and P113. Comparison of the β-haemolysis and growth 
profile of P13 and P113 demonstrated that P113 was better adapted to growth in laboratory 
medium. Comparison of P13 and P113 in a murine model fed with a zinc-deficient diet showed 
that mice infected with P113 produced less disease and that P113 has been partially attenuated. 
Genotypic comparison by random amplified polymorphic DNA (RAPD) and genome sequencing 
showed that there were no detectable differences in the genome profiles or sequences. Overall, a 
partially attenuated and laboratory adapted “B. hampsonii” strain was produced by serial passage. 
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3.2 Introduction 
Swine dysentery, due to B. hyodysenteriae, was under control until the re-emergence of 
mucohaemorrhagic diarrhea started in the mid-2000s (Burrough, 2016). This re-emergence has 
been associated with “Brachyspira hampsonii”, a Gram-negative, facultative anaerobic, and motile 
spirochaete. “B. hampsonii” was identified in 2009 as distinct from other Brachyspira spp. based 
on sequence differences in the NADH-oxidase (nox) gene (Harding et al., 2010) and has 
subsequently been proposed as a novel species (Chander et al., 2012, Mirajkar et al., 2016). 
Clinical isolates of “B. hampsonii” have demonstrated a high degree of virulence in swine, leading 
to mucohaemorrhagic diarrhea (Rubin et al., 2013a).  
Control of “B. hampsonii” is possible through the use of biosecurity, antibiotics, and 
depopulation. The role of biosecurity is to prevent the exposure of swine to “B. hampsonii”, while 
antibiotics are used to treat infected swine. Depopulation-repopulation is the removal of swine 
from the farm, decontamination of facilities, and eventual repopulation with a new herd. The 
method of depopulation-repopulation has been shown to be effective in removing Brachyspira 
spp. from the farm, but facilities remain at risk for reinfection due to environmental and wildlife 
reservoirs of Brachyspira spp. (Aarestrup et al., 2008). A more effective tool that would help 
prevent outbreaks and possibly aid with regional eradication of “B. hampsonii” would be a vaccine. 
Several approaches to Brachyspira vaccine production have been pursued with varying success. 
 Recombinant protein B. hyodysenteriae vaccines have been composed of outer membrane 
proteins such as BmpB, which has been shown to be partially protective against at least one other 
serotype from the serotype the protein was originally isolated from (La et al., 2004). Another outer 
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membrane protein, SmpB, was evaluated as a vaccine candidate and found to provide 50% 
protection against B. hyodysenteriae in mice (Holden et al., 2008). However, vaccination with 
multiple outer membrane proteins is likely needed since only SmpA has been detected in Spanish 
isolates, while SmpA and SmpB are equally distributed in US isolates (Holden et al., 2008, 
Hidalgo et al., 2010). Further studies have been performed to improve the outer membrane-type 
vaccines through different vaccine strategies (DNA vaccine, BmpB protein in a carrier 
microparticle coated with M cell targeting peptide) or through modification of antigen proteins 
through fusion with unrelated domains (poly-histidine, maltose-binding protein, glutathione S-
transferase) (La et al., 2005, Holden et al., 2008, Jiang et al., 2014). Although sera from vaccinated 
pigs has been shown to recognize outer membrane extracts from multiple B. hyodysenteriae 
serotypes, in vivo serotype cross-protection has not yet been demonstrated (La et al., 2004, Lee et 
al., 2000).   
Live attenuated B. hyodysenteriae strains have been developed by Hudson et al. (1974) and 
Kinyon et al. (1977) by serial passage of a swine-virulent B. hyodysenteriae in vitro. However, 
failure of heterologous protection between B. hyodysenteriae serotypes has also been raised as a 
concern based on attempts at live attenuated vaccination, which may be associated with the 
variable expression of the major outer membrane proteins (Bhmp) of B. hyodysenteriae (Joens et 
al., 1983, Witchell et al., 2006).  
A challenge for live attenuated vaccine development for “B. hampsonii” is the lack of genetic 
systems for specific modification of genes and a lack of knowledge of virulence determinants to 
target, even if it were possible to perform targeted manipulations. Random mutagenesis of virulent 
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strains to produce live attenuated vaccine candidates is impractical due the large numbers of strains 
that would need to be screened in vivo. However, laboratory attenuation through serial passage has 
proven to be effective in reducing the virulence of Brachyspira hyodysenteriae, without knowledge 
of virulence determinants  (Kinyon et al., 1977). In vitro serial passage of B. hyodysenteriae has 
also led to the reduction of antibiotic resistance towards tylosin (Kitai et al., 1987). The method of 
attenuation by serial passaging has also been effective for other bacteria, such as Staphylococcus 
aureus (Somerville et al., 2002), and commercial live attenuated vaccines are marketed for control 
of pathogens such as Lawsonia intracellularis (Enterisol Ileitis, Boehringer Ingelheim) and 
Erysipelothrix rhusiopathiae (Ingelvac ERY-ALC, Boehringer Ingelheim) in pigs. Serial passage 
has been shown to lead to changes in the genome, such as changes in genome structure and 
sequence alterations in a wide range of genes (Fux et al., 2005, Somerville et al., 2002). Serial 
passage of Staphylococcus aureus resulted in reduced production of virulence factors, due to 
mutations in specific genes, such as agr which led to inactivation of quorum sensing, a decrease 
in secretion of α-toxins, and improved growth yield in vitro (Somerville et al., 2002). Thus, in 
addition to producing a live attenuated vaccine candidate, attenuation by serial passage may also 
lead to changes in the virulence that would in turn lead to identification of genes linked to virulence 
determinants.  
The objective of the current study was to produce an attenuated “B. hampsonii” strain by 
serial passage of an isolate previously demonstrated to be virulent in pigs. Changes in phenotypic 
and genotypic characteristics of the bacterium that occurred as a result of the attenuation process 
were assessed, and the effect of the attenuation process on virulence was determined in a mouse 
model.  
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3.3 Materials and Methods 
Brachypsira isolates and culture conditions 
The strain selected for serial passaging was “B. hampsonii” D09-30446 passage 13 (P13), 
a clade II strain of “B. hampsonii”, which was originally isolated from intestinal contents from a 
13-week old pig with mucohaemorrhagic diarrhea as described by Rubin et al. (2013a). “B. 
hampsonii” D11-30599 (clade I) was selected for genome profile comparisons as a representative 
of clade I “B. hampsonii”. Type strains of other Brachyspira spp. were obtained from the American 
Type Culture Collection (ATCC). B. hyodysenteriae ATCC 27164T and B. pilosicoli ATCC 
51139T were used as controls for the indole spot test, hippurate hydrolysis test, and genome profile 
comparisons. B. murdochii ATCC 51284T was used for genome profile comparisons. 
Brachyspira spp. were cultured in BHIS broth (brain heart infusion (BHI) broth + 10% 
(v/v) fetal bovine serum) or JBS broth (BHI + 5% (v/v) deactivated fetal bovine serum + 5% (v/v) 
defibrinated sheep blood) in glass vials containing magnetic stir bars. Broth cultures were 
incubated at 39°C under anaerobic conditions with constant stirring, using a commercial gas packet 
system (Anaerogen, Oxoid Limited, Basingstoke, UK) (Rubin et al., 2013a). For growth on solid 
media, Brachyspira spp. were streaked on to BJ agar (trypticase soy agar + 5% (v/v) defibrinated 
sheep blood + 5% pig faeces extract + 25 µg/mL spiramycin + 12.5 µg/mL rifampin + 6.25 µg/mL 
vancomycin + 6.25 µg/mL colistin + 200 µg/mL spectinomycin) (Kunkle and Kinyon, 1988). Agar 
plates were incubated anaerobically at 42°C for 24 to 72 hours (Songer et al., 1976, Rubin et al., 
2013a). Long-term storage of Brachyspira spp. isolates was in brain heart infusion (BHI) broth + 
10% (v/v) glycerol at -80°C.  
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3.3.1 Serial passage 
The initial culture of “B. hampsonii” D09-30446 P13 was grown in 10 mL JBS in duplicate. 
For serial passages, 1 mL of broth culture was transferred to fresh JBS broth (9 mL) once a dense 
culture had been achieved (usually 1-3 days, but occasionally up to 6 days). The presence of active 
spirochaetes in the donor culture was confirmed by phase contrast microscopy prior to each 
passage. Periodically, Gram-staining was performed on BHIS cultures grown from select JBS 
passage cultures, to check for obvious contaminants. The serial passage of P13 for 100 passages 
resulted in “B. hampsonii” D09-30446 passage 113 (P113). A minimum of four 1 mL aliquots of 
all passages, from P14 to P113 were stored at -80°C. 
3.3.2 Biochemical characterization 
 “B. hampsonii” P13 and P113 cultures were grown in BHIS broth to the mid-log phase per 
the “B. hampsonii” clade II growth curve previously established in the lab. For the API-zym test, 
cultures were standardized to a turbidity of McFarland 5, per manufacturer’s instructions 
(BioMérieux, St. Laurent, QC). Hippurate hydrolysis and spot indole tests were performed as 
previously described (Fellström and Gunnarsson, 1995). B. hyodysenteriae ATCC 27164T and B. 
pilosicoli ATCC 51139T were included as controls for the indole spot and hippurate hydrolysis 
tests. 
3.3.3 β-haemolysis assays 
Haemolysis activity of Brachyspira isolates was evaluated using two approaches. For 
qualitative assessment, BJ agar plates were streaked with isolates using a standard four-streak 
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pattern (3 replicate plates per isolate per time point; 12 total replicate plates per isolate). A 10µL 
inoculation loop was used for streaking to standardize the amount of inoculum. Plates were 
observed after 1, 2, 3 and 4 days of anaerobic incubation and haemolysis was scored according to 
the presence of visible β-haemolysis in quadrants 1-4. An average of scores from each of the three 
replicate plates for each isolate at each time point was calculated.  
For quantitative evaluation of haemolysis, the wells of 96-well flat-bottomed plates 
(Greiner Bio-One, Kremsmünster, AT) were each filled with 150 µL of BJ agar. Active cultures 
of “B. hampsonii” P13 and P113, grown in BHIS, were adjusted to a McFarland 5 turbidity, using 
a densitometer (Grant-Bio, Kensington, UK). Wells containing BJ agar were inoculated with 5µL 
of “B. hampsonii” P13 or P113 (20 biological and 6 technical replicates each). Each plate also 
contained 12 wells inoculated with sterile BHIS, as a negative control. Plates were incubated at 
42°C under anaerobic conditions for 4 days, under humid conditions. Absorbance measurements 
at 560 nm were made at hours 0, 24, 48, 72, and 96 using the Vmax plate reader (Molecular 
Devices, Sunnyvale, CA). A haemolysis score was calculated for each well at each time point 
using the following formula:(𝑂𝐷600 𝑡𝑒𝑠𝑡 − 𝑂𝐷600 𝑐𝑜𝑛𝑡𝑟𝑜𝑙) × −1 = ℎ𝑎𝑒𝑚𝑜𝑙𝑦𝑠𝑖𝑠 𝑠𝑐𝑜𝑟𝑒. For the 
haemolysis plate assay, raw data was compared by Repeated Measures ANOVA. 
3.3.4 Growth study 
The growth rates of “B. hampsonii” P13 and P113 were compared to detect differences in 
growth rates of the two strains. Three replicate cultures were prepared for each strain and each 
time point (0, 12, 24, 36, 48, and 72 hours). McFarland 5 standardized cultures (0.33 mL) were 
inoculated into 3.3 mL of BHIS broth, for incubation in smaller tubes (7 mL vials, 17mm × 60mm; 
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VWR, Radnor, USA). Broth cultures were incubated at 39°C with stirring, under anaerobic 
conditions. Optical density measurements at 600 nm were taken in polystyrene cuvettes using a 
spectrophotometer. The average optical density of each time point for both P13 and P113 were 
compared by Repeated Measures ANOVA. 
3.3.5 Random amplified polymorphic DNA (RAPD) genome fingerprinting 
RAPD fingerprinting was conducted as described by Quednau et al. (1998) and Jansson et 
al. (2004). “B. hampsonii” P13 and P113, “B. hampsonii” D11-30599, B. hyodysenteriae ATCC 
27164T, B. pilosicoli ATCC 51139T, and B. murdochii ATCC 51284T were grown in BHIS to a 
dense culture, then boiled for 10 minutes to release DNA. RAPD-PCR was performed on the boiled 
samples using 1.09× PCR buffer (0.2 M Tris-HCl (pH 8.4), 0.5 M KCl), 3.26 mM MgCl2, 0.44 
µM JH0724 (5’-ACGCGCCCT-3’) or JH0725 (5’-CCGCAGCCAA-3’), 4.4 mM dNTPs, 0.0054 
U Taq, and 34.5 µL ultra-pure water in a total volume of 50 µL. The RAPD-PCR was run on a 
Mastercycler (Eppendorf, Hamburg, Germany) using the following settings: 4 cycles (94°C for 45 
sec, 30°C for 2 min, and 72°C for 1 min), 26 cycles (94°C for 5 sec, 36°C for 30 sec, and 72°C for 
30 sec with one additional sec added per cycle), final extension at 72°C for 10 min, and a hold at 
4°C (Quednau et al., 1998). 
PCR products (10 µL of each reaction) were loaded into a 1.5% agarose gel, then run for 
2.5 hours at 100V. The gel was stained with ethidium bromide, visualized and photographed under 
UV light. The resulting image was analyzed using the Gel-Compar II software (Applied Maths, 
Austin, TX). Banding patterns were clustered using UPGMA clustering of Dice co-efficient with 
optimization and position tolerance settings of 0.00% and 1.00 % respectively.  
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3.3.6 Genome sequencing 
3.3.6.1 Preparation of DNA and genome libraries 
Genomic DNA was isolated from “B. hampsonii” P13 and P113 cultures grown in BHIS 
broth medium by modified salting out procedure (Martin-Platero et al., 2007). Concentration of 
genomic DNA extracts was measured using a spectrophotometer and A260/A280 ratio was 
measured to confirm purity. PCR targeting and sequencing of the nox gene was performed to verify 
that the genomic DNA of both P13 and P113 belong to clade II, as previously described by Atyeo 
et al. (1999). 
The library preparation was followed as outlined by the Illumina Nextera Mate Pair Sample 
Preparation Guide (Illumina, San Diego, CA). The index adapters utilized were AD002 
(GCCAAT(A)) and AD012 (CTTGTA(A)). Average size of the final amplicon libraries in base 
pairs (bp) was calculated using the DNA High-Sensitivity chip on the 2100 Bioanalyzer (Agilent 
Technologies, Inc., Santa Clara, CA) and concentration in ng/L assessed using the Qubit 
fluorometer (Life Technologies, Inc., Burlington, ON). PhiX DNA (15% (v/v)) was added to the 
pooled indexed libraries prior to loading onto the flow cell. Sequencing was performed using the 
500 cycle (2  250) V2 Nano platform. 
3.3.6.2 Sequence data processing and genome assembly 
Raw mate-pair sequence reads in fastq format were trimmed for quality using 
Trimmomatic (Bolger et al., 2014) with a minimum read length of 50 and quality cut-off of Phred 
score >30. High quality paired reads were carried forward to adapter clipping. Mate-pair adapter 
50 
 
sequences were identified and reads trimmed to the adapter location using NextClip (Leggett et 
al., 2014), which results in classification of reads into four categories: A, where the adapter is 
detected in both Read 1 and Read 2 of the mate-pair; B, adapter in Read 2 only; C, adapter in Read 
1 only; D, adapter not detected in either read. Reads from categories A-C were included in further 
analysis and assembly. 
To estimate genome coverage, and calculate average insert size, mate-pair reads were 
mapped on to the reference genome assembly for “B. hampsonii” strain 30446 (Genbank 
Accession NZ_ALNZ00000000) using Bowtie2 (Langmead and Salzberg, 2012) and the results 
were converted to BAM format for viewing in Qualimap v2.2.1 (Okonechnikov et al., 2016). 
Genome assembly was done using all reads from NextClip categories A-C as input for 
SOAPdenovo2 (Luo et al., 2012), using estimated average insert size from Qualimap analysis. 
Overall genome sequence similarity between P13, P113 and additional reference genomes 
from other Brachyspira species was calculated using Average Nucleotide Identity by Mummer 
(ANIm) and tetranucleotide scores within JSpecies (Richter and Rossello-Mora, 2009). 
3.3.7 Virulence assessment in mice 
The experiments were designed and performed in accordance with the Canadian Council 
for Animal Care and all work was approved by the University of Saskatchewan Animal Research 
Ethics Board (protocol 20150015). 
3.3.7.1 Experiment 1 – P13 and P113 
Twenty, six-week old, female CF1 mice (Charles River, Wilmington, MA) were randomly 
assigned into groups of 4 mice per cage and labelled using tail markings applied with black markers 
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(Ek et al., Submitted). The mice were fed a low-zinc diet, TD8540 (Envigo, Indianapolis, IN) ad 
libitum. After one week of acclimatization, mice in each group were inoculated on three 
consecutive days with 0.3 mL (~108 genomic equivalents in JBS) of P13 (n=8), P113 (n=8), or 
sham (sterile JBS, n=8) by oral gavage using a 20 gauge blunt-ended feeding needle. Feed was 
removed six hours prior to inoculation. Health checks (hair condition, behaviour) were performed 
twice daily. Mice were weighed on Days -6, -2, 0 (prior to inoculation), 5, 7, 9, 12, 14, 16, and at 
termination (Day 19 post-inoculation (PI)) for the calculation of average daily gain (ADG = total 
weight gained/number of days). Faecal pellets were collected for selective Brachyspira culture on 
BJ agar on Days -2, 0 (prior to inoculation), 5, 7, 9, 12, 14, and 16. Caecal swabs were collected 
at termination (Day 19 PI) during necropsy. Faecal scoring was performed twice a day (morning 
and afternoon) throughout the experiment. Faecal consistency was scored as: 0 = normal/formed, 
1 = formed with slight mucus, 2 = formed with abundant mucus, 3 mild (3m) = mucus only/soft 
faeces only, 3 severe (3s) = soft and very mucoid, 4 = soft and very mucoid with blood (Figure 
3.1). 
3.3.7.2 Experiment 2 – P13, P113, and MP1 
Thirty, six-week old, female CF1 mice (Charles River, Wilmington, MA) were randomly 
assigned into pairs (2 mice per cage). The mice were fed a low-zinc diet, TD8540 ad libitum. After 
one week of acclimatization, each mouse group was inoculated by oral gavage on three consecutive 
days with 0.3 mL (~108 genomic equivalents in JBS) of P13 (n=8), P113 (n=8), MP1 (n=8), or 
sham (sterile JBS, n=6). MP1 (mouse passage 1) was an isolate recovered from the colon of the 
mouse infected with P113 from Experiment 1 with the fewest abnormal fecal scores (mouse P113-
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7). Health checks, weight measurements, ADG calculations, and faecal pellet collection and 
culture were performed as done in Experiment 1. A modification to the faecal consistency scoring 
was made to add to the existing scoring system: score 0.5 = slightly soft, but formed (Figure 3.1). 
The second experiment ran for 19 days PI, however the diet was changed from TD8540 to regular 
rodent chow on Day 13 PI due to the exhaustion of TD8540 stocks. For this reason, only the data 
collected from Days -6 to 12 PI was used for analysis to avoid any potential effects of the diet 
change on health and faecal outcomes. 
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Figure 3.1. Faeces scoring sheet for Experiment 1 and 2. Score 0.5 was not used for Experiment 
1. The scores represent the following faecal outcomes: 0 – formed pellet, 0.5 – slightly soft but 
formed pellet, 1 – formed pellet with a mucus tail or mucus on one end, 2 – formed pellet coated 
with mucus, 3m – mucus only/soft faeces only, 3s – mucus mixed with faeces (yellow mucus)/very 
soft faeces coated with copious amounts of mucus, 4 – mucus with faeces and some blood specks 
mixed in. 
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3.3.7.3 Statistics for Experiment 1 and 2 
For Experiment 1, the mean ADG (a period from Day 0 to 19) for each group (P13, P113, 
or sham) were compared using the Kruskal-Wallis test. The average count of faecal scores ≥ 2 
from Day 3 to 19 for each group (P13, P113, or sham) were also compared by Kruskal-Wallis. 
For Experiment 2, the mean ADG (a period from Day 0 to 12) for each group (P13, P113, 
MP1, or sham) and the average count of faecal scores ≥ 2 from Day 3 to 12 for each group (P13, 
P113, MP1, and sham) were also compared by Kruskal-Wallis. 
 
3.4 Results 
3.4.1 Phenotypic characteristics of P13 and P113 
3.4.1.1 Serial passage 
A total of 100 passages of P13 were done, resulting in strain P113. The time required to 
reach a dense culture under the growth conditions described was usually 1-3 days, although 
occasionally longer periods (up to 6 days) were required. No contamination was detected during 
serial passage. No changes to morphology were noted in Gram stains and phase-contrast images 
of P13 and P113 (Figure 3.2). 
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a) 
 P13 P113 
  
b) 
 P13 P113 
  
Figure 3.2. Phase-contrast (a) and Gram-stained (b) images of P13 and P113. Material present in 
the background of phase-contrast images were red blood cells, present in the JBS cultures used for 
phase-contrast imaging. 
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3.4.1.2 Biochemical characterization 
To detect any changes to diagnostic biochemical characteristics, P13 and P113 were 
evaluated by API-zym, indole, and hippurate hydrolysis tests. B. hyodysenteriae ATCC 27164T 
and B. pilosicoli ATCC 51139T were included for the indole and hippurate assays to ensure that 
the assays were producing correct reactions. The API-zym assay resulted in positive β-glucosidase, 
negative α-galactosidase, and negative α-glucosidase activities for both P13 and P113 (Table 3.1). 
Negative hippurate hydrolysis and indole spot assay activities were also detected for both P13 and 
P113. The results for B. hyodysenteriae ATCC 27164T (indole positive and hippurate negative) 
and B. pilosicoli ATCC 51139T (indole negative and hippurate positive), were as expected. P13 
was α-chymotrypsin negative, but a positive result was obtained for P113. Additionally, a 
difference was observed in β-glucuronidase results, with P113 giving a weak positive result 
compared to the negative result for P13.   
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Table 3.1. Biochemical profile of P13 and P113. 
  
D09-30446 
P13 
D09-30446 
P113 
Alkaline phosphatase + + 
Esterase (C4) + + 
Esterase Lipase (C8) + + 
Lipase (C14) - - 
Leucine arylamidase - - 
Valine arylamidase - - 
Cystine arylamidase - - 
Trypsin - - 
α -chymotrypsin - + 
Acid phosphatase + + 
Naphthol-AS-BI-phosphohydrolase W+ W+ 
α-galactosidase - - 
β -galactosidase + + 
β -glucuronidase - W+ 
α-glucosidase - - 
β -glucosidase + + 
N-acetyl-β-glucosaminidase - - 
α-mannosidase - - 
α-fucosidase - - 
Hippurate hydrolysis - - 
Indole production - - 
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3.4.1.3 β-haemolysis assays 
β-haemolysis was qualitatively assessed using a four-streak pattern on BJ agar. All P113 
replicates reached quadrant 3 by Day 3 and one had reached quadrant 4 by Day 4. Only one of the 
P13 replicates reached quadrant 3 and only after 4 days of incubation (Figure 3.3).  
The β-haemolysis activities of P13 and P113 were quantified to detect differences not 
detectable by qualitative methods. Results of the 96-well plate assay are shown in Figure 6. 
Haemolysis of BJ agar by P13 was greater than P113 at day 1 (p<0.05, Repeated Measures 
ANOVA), but remained at similar levels the following days (Figure 3.4). Whereas, the haemolysis 
performed by P113 continually increased over the 4 days and was greater than P13 on days 3 and 
4 (p<0.05, Repeated Measures ANOVA) (Figure 3.4).  
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Figure 3.3. Qualitative assessment of β-haemolysis on BJ agar over 4 days. Each of three replicate 
plates for strains P13 and P113 were evaluated. Haemolysis score (quadrant number) is indicated 
by colour according to the legend.  
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Figure 3.4. Quantitative assessment of P13 (black, n=120) and P113 (red, n=120) β-haemolytic 
activity (absorbance × –1) over 4 days. Error bars represent standard deviation. Significant 
differences (p<0.05, Repeated Measures ANOVA) are indicated by asterisks (*).  
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3.4.1.4 Growth study 
To determine if the explanation for the unexpected observation of greater haemolysis 
activity for P113 compared to P13 was related to growth rate of the laboratory adapted P113 rather 
than a change in the specific activity of haemolytic factors, the growth rates of the two strains were 
compared. Triplicate cultures were prepared for each time point (hours 0, 12, 24, 36, 48, and 72). 
Logarithmic growth of P113 started at 12 hours and the optical density of P113 cultures were 
greater than P13 cultures over the 72-hour period, except for hours 36 and 72 (Figure 3.5). The 
average optical density for two of three replicates of P113 at hour 36 had very little growth 
resulting in an unexpectedly low average OD for that time point. Exponential growth of P13 did 
not begin until between hours 36 and 48. P113 reached the stationary phase between 48 and 72 
hours, while a stationary phase was not observed for P13 during the experiment (Figure 3.5). 
There was significantly greater growth of P113 at 12, 24, and 48 hours and significantly more 
overall P113 growth (p=0.047, Mann-Whitney U).  
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Figure 3.5. Growth study of P13 (black, n=3 per time point) and P113 (red, n=3 per time point) in 
broth medium over a 72-hour period. Error bars represent standard deviation. Significant 
differences (p<0.05, Mann Whitney U) are denoted by asterisks (*).  
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3.4.2 Genome fingerprinting by RAPD 
Visual inspection of banding patterns of replicate RAPD profiles from individual 
Brachyspira spp. indicated high reproducibility of banding patterns. RAPD profiling of P13 and 
P113 were 96.3% and 94.1% identical to each other based on primers JH0724 or JH0725, 
respectively (Figure 3.6a & b). “B. hampsonii” clade I strain 30599 was 62.5 & 58.1% and 37.5 
& 50.0% identical to P13 and P113, respectively, based on RAPD with primers JH0724 or JH0725. 
RAPD patterns of other species of Brachyspira spp. were easily distinguished from “B. 
hampsonii” with only 47.1 – 76.1% similarity to P13 and P113 depending on the species and the 
primer used (Figure 3.6a & b). 
3.4.3 Whole genome sequencing 
Whole genome sequencing yielded a total of 816,716 and 909,529 raw reads for P13 and 
P113, respectively. Details of the numbers of reads surviving quality clipping, identification of 
paired reads and adapter trimming are shown in Table 3.2. A total of 520,555 and 545,614 reads 
were available for Bowtie2 mapping and genome assembly for P13 and P113, respectively. De 
novo genome assembly results are summarized in Table 3.3. Bowtie2 mapped >98% of reads from 
either genome to the “B. hampsonii” 30446 reference genome, and coverage was calculated as 24-
25 for both sequenced genomes. The median insert size for the mate-pair fragments was 4,058 
for P13 and 2,435 for P113. N50 values were low, indicating a highly fragmented genome 
assembly, although coverage was apparently complete with ~3 Mb of total contig length for both 
genomes (reference genome size: 3,071,124 bp). G+C content was ~27.5% for both P13 and P113. 
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Comparison of the P13 and P113 showed high similarity based on tetra scores (0.99675 – 
0.99982 similar) and ANIm values (99.77 – 99.8% similar) (Table 3.4). Clade I “B. hampsonii” 
D11-30599 was highly similar by tetra scores to P13 (0.99675) and P113 (0.99717) and by ANIm 
to P13 (93.65-93.68%) and P113 (93.66-93.69%) (Table 3.4). 
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a) 
 
b) 
 
Figure 3.6. RAPD profile comparison of several Brachyspira spp. and strains using primers 
JH0724 (a) and JH0725 (b) by clustering of banding patterns using UPGMA clustering of Dice 
co-efficient with optimization and position tolerance settings of 0.00% and 1.00 % respectively.  
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Table 3.2. Raw read numbers and results of trimming for quality and adapter sequences. 
 P13 P113 
Number reads raw 816,716 909,529 
Number paired  
(post-Trimmomatic) 
720,154 754,209 
NextClip A 208,466 229,096 
NextClip B 137,894 143,343 
NextClip C 174,195 173,175 
Total post-NextClip 520,555 545,614 
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Table 3.3. De novo assembly results for P13 and P113. 
 D09-30446 
P13 
D09-30446 
P113 
Sequencing 
coverage (×) 
24.1 25.2 
Mate pair 
insert size 
(median) 
4 058 bp 2 435 bp 
N50 1 562 bp 1 774 bp 
Longest contig 12 764 bp 34 186 bp 
Total contig 
length 
3 032 560 bp 3 082 682 bp 
No. of contigs 
(>500 bp) 
2 093 1 939 
%GC 27.56% 27.51% 
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Table 3.4. Tetra (a) and ANIm (b) scores of pairwise comparisons of P13, P113, and reference 
genomes. 
a) 
Isolate P13 P113 D09-30446 D11-30599 
B. hyodysenteriae 
ATCC 27164T 
P13 — 0.99675 0.99985 0.99717 0.9872 
P113 0.99982 — 0.9999 0.99675 0.98697 
D09-30446 0.99985 0.9999 — 0.99681 0.9872 
D11-30599 0.99717 0.99675 0.99681 — 0.98703 
B. hyodysenteriae 
ATCC 27164T 
0.9872 0.98697 0.9872 0.98703 — 
 
b) 
Isolate 
P13 P113 D09-30446 D11-30599 
B. hyodysenteriae 
ATCC 27164T 
P13 — 99.77 99.87 93.68 89.17 
P113 99.8 — 99.89 93.69 89.15 
D09-30446 99.84 99.84 — 93.54 88.7 
D11-30599 93.65 93.66 93.55 — 89.18 
B. hyodysenteriae 
ATCC 27164T 
89.17 89.13 88.73 93.54 — 
 
  
69 
 
3.4.4 Virulence in a mouse model 
In Experiment 1, mouse behaviour did not differ between the sham, P13, and P113 groups. 
The calculated ADG also did not differ significantly between among groups (Table 3.5; NS, 
Kruskal-Wallis). There were no faecal scores 2 for the sham group, while the P113 group had 
fewer scores 2 than the P13 group. Differences in the number of daily faecal scores ≥2 were 
significant between all the groups (Kruskal-Wallis, p<0.05) and the number of faecal scores ≥2 in 
P13-inoculated mice was greater than P113- and sham-inoculated mice (Figure 3.7a; Kruskal-
Wallis, p<0.05). On days when abnormal feces were observed, it was often observed in individual 
mice either in the morning or afternoon observation periods, but not both, which has also been 
observed by our group in swine trials (Figure 3.7). Mouse P113-7 had the fewest faecal scores ≥2 
within the P113 group (n=4). To explore the possibility of further attenuation of P113 resulting 
from mouse passage or selection of a particularly avirulent subpopulation of P113 in this mouse, 
strain MP1 (mouse passage 1) was isolated from the colon of P113-7 upon termination for use as 
inoculum in Experiment 2. 
In Experiment 2, mouse behaviour did not differ between the sham, P13, P113, and MP1 
groups. The calculated ADG also did not differ significantly between all the groups (Table 3.5; 
NS, Kruskal-Wallis). The average count of faecal scores between all groups was significantly 
different, except between P113 and MP1 (Kruskal-Wallis, p < 0.05). The P13 group had the highest 
average count of faecal scores ≥2 (Figure 3.7b). Abnormal fecal scores were also observed in the 
sham group in this experiment. Due to low TD8540 feed stocks, less food was available 5 days PI, 
which may have acted as a stressor for all groups.   
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Table 3.5. Calculated average daily gain of mice for Experiment 1 and 2. No significant difference 
was detected by Kruskal-Wallis. 
    
Average ADG 
(g/day) 
Standard 
Deviation 
Experiment 
1 
Sham (n=4) 0.1641 0.1058 
P113 (n=8) 0.1869 0.0473 
P13 (n=8) 0.1589 0.1177 
Experiment 
2 
Sham (n=6) 0.0450 0.1699 
MP1 (n=8) 0.2292 0.1677 
P113 (n=8) 0.2061 0.1034 
P13 (n=8) 0.1841 0.1200 
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a) 
 
b) 
 
Figure 3.7. Heatmaps representing the daily faecal score (AM & PM) of each mouse in the 
different groups for Experiment 1 (a) and Experiment 2 (b). The faecal scores are labelled by 
colour in the legend for each heatmap, ND indicates no data was collected. T indicates the 
termination day. For both Experiment 1 (termination - caecum) and 2 (last day of trial with low-
zinc diet – faecal pellet), results of spirochaete recovery by culture are under the final day 
included as positive (+), negative (–), or no data (/). Feed rationing in Experiment 2 started 5 
days PI.  
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a) 
 
b) 
 
Figure 3.8. Average count of faecal scores ≥2 per group for Experiment 1 (a) (nSham=4, 
nP13/P113=8) and Experiment 2 (b) (nSham=6, nMP1/P13/P113=8). Error bars represent the standard 
deviation. Significantly different groups are denoted by different letters (p<0.05, Kruskal-
Wallis).  
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3.5 Discussion 
In vitro serial passage of a pathogenic “B. hampsonii” clade II strain D09-30446 was 
performed as a method of producing an attenuated vaccine candidate, based on previous 
experiences by other groups producing attenuated strains after several serial passages in vitro 
(Kinyon et al., 1977). The resulting P113 strain was phenotypically (biochemical profile, β-
haemolysis, growth curves, virulence in a mouse model) and genotypically (genome structure and 
sequence comparison) characterized, relative to the original, virulent P13 strain.  
An attenuated “B. hampsonii” strain could be useful for vaccine production, but may also 
aid in the identification of virulence factors since comparison of virulent and attenuated strains 
may highlight changes linked to virulence in swine. In this study, we examined biochemical 
characteristics used to define Brachyspira species, β-haemolysis activity, genome structure, and 
genomic content. Brachyspira spp. were historically identified and differentiated based on a profile 
of biochemical markers (α-galactosidase, α-glucosidase, β-glucosidase, hippurate hydrolysis, and 
indole production) and strength of β-haemolysis, although variation in these biochemical markers 
has been reported in several Brachyspira spp. (De Smet et al., 1998, Fellström et al., 1999). Strong 
β-haemolysis has been associated with more severe illness in swine, while milder disease is 
associated with weakly β-haemolytic Brachyspira spp. (Burrough, 2016, Trott et al., 1996c). The 
reliability of the strength of β-haemolysis as a marker for virulence is in question though as 
variability has been detected in the degree of β-haemolysis of B. hyodysenteriae on blood media, 
with some clinical isolates producing lower degrees of β-haemolysis (Mahu et al., 2016).  
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Characterization of biochemical profiles of “B. hampsonii” P13 and P113 indicated no 
detectable changes in established diagnostic characteristics (Table 3.1). Differences in α-
chymotrypsin and β-glucuronidase were observed, but cannot be interpreted since the degree of 
variation in these tests among “B. hampsonii” isolates has not been reported. Mutations of 
metabolic enzymes have been associated with attenuation in other systems, such as changes in 
glycerol dehydrogenase, an enzyme associated with virulence in Mycoplasma gallisepticum, 
leading to attenuation of strains (Szczepanek et al., 2010). However, the lack of detectable changes 
in diagnostic biochemical markers in our study was not surprising, since these historically 
characterized markers have not been strongly linked to the level of pathogenicity of Brachyspira 
spp. (Achacha and Messier, 1991, De Smet et al., 1998, Perez et al., 2016).  
The morphology of P113 did not differ from P13 based on a qualitative observation of Gram-
stain and phase-contrast images (Figure 3.2). However, this is not a surprising result since major 
changes, such as greater sensitivity of Brachyspira to low pH that leads to the spherical 
morphotype (Bernardeau et al., 2009) or changes in the membrane composition as observed in 
Borrelia burgdorferi (LaRocca et al., 2013), would have to occur for bacterial cell morphology to 
change.  
Attenuation of virulence has been attributed to modification of haemolysis pathway 
enzymes, such as agr in S. aureus (Somerville et al., 2002). Given that strong β-haemolysis is 
considered a potential virulence factor of swine pathogenic Brachyspira spp., we anticipated that 
the putatively attenuated P113 would exhibit less haemolytic activity than P13. However, both the 
qualitative and quantitative assays suggested the opposite pattern with more haemolytic activity 
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observed for P113 (Figure 3.3, Figure 3.4). To determine if the difference was due to a modified 
haemolysin or due to an improvement in the growth of P113, we compared the growth rates of the 
two strains (Figure 3.5). The results highlight that the difference in haemolysis patterns is likely 
due to an improvement in the growth rate of P113 on BJ agar, rather than an increase in the 
haemolysis strength of P113. This is consistent with the culture adaptation of P113 through serial 
passage in the laboratory.  
The genome profiling performed for P13 and P113 indicated no detectable difference 
between the two, based on RAPD profiling (Figure 3.6). The separation of other Brachyspira spp., 
a clade I “B. hampsonii” reference isolate, P13, and P113 by RAPD shows that the method is 
capable of differentiating clades within the species. These results also indicate that serial passage 
did not result in large-scale genomic changes such as major deletions or re-arrangements. To 
investigate genome changes at a more detailed level, we determined the whole genome sequences 
of P13 and P113. Mate-pair genome sequencing and de novo assembly of both P13 and P113 
produced highly similar genomes based on the genome size, G+C content and sequence content 
determined by tetra scores (0.99675 – 0.99982 similar) and ANIm values (99.77 – 99.8% similar) 
(Table 3.3, Table 3.4). Comparison of the genome profile and sequence have so far have not 
produced any detectable differences, however ongoing supplementation of the current data with 
paired-end sequences will improve the assembly quality, permitting annotation and aiding with 
detection of smaller changes between the genomes resulting from the laboratory attenuation 
process.  
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Infection studies of swine-virulent Brachyspira spp. have primarily used swine models to 
study the effects of the spirochaete on the primary animal of concern. However, some studies have 
also utilized different mouse models to study the effects of Brachyspira spp. on the mouse 
intestine. A more recent study has shown that one particular strain of mice (CF1), fed with a low-
zinc diet, produced more mucus and soft faeces when infected with B. hyodysenteriae and “B. 
hampsonii” compared to sham-inoculated mice (Ek et al., Submitted). Mouse models are also 
appealing as they are more cost efficient and less sentient models. “B. hampsonii” P13 and P113 
were both compared in a mouse model to assess the relative virulence of P113.  
In Experiment 1, all mice inoculated with P113 had some abnormal fecal scores, but mice 
in this group had significantly fewer faecal scores ≥2 than controls or mice inoculated with P13. 
No difference was observed in ADG or mouse health (indicated by fur condition and behaviour) 
(Table 3.5). Similar results were obtained in Experiment 2 for controls, P13 and P113. Experiment 
2 was complicated by the low availability of TD8540 feed and rationing of food 5 days PI. This 
stressor may be responsible for the observation of some higher faecal scores in sham group, which 
were not observed in Experiment 1 (Figure 3.8). Loss of body weight and higher mortality due to 
peritoneal infection after a period of fasting have been observed in mice, which may explain the 
higher number of abnormal faecal scores in all groups in Experiment 2 (Bermudes et al., 2011).  
To investigate the possibility that passage through mice might further attenuate virulence or 
select for less virulent subpopulations within P113, we isolated MP1 from feces of the mouse in 
Experiment 1 with the lowest overall fecal scores and used this isolate to challenge mice in 
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Experiment 2. However, no difference in the occurrence of abnormal fecal scores was detected 
between the MP1 and P113 groups.  
Taken together, the results of the mouse infection studies show that partial attenuation has 
been achieved, however further experimental infection in swine will be required to determine if 
virulence is also attenuated in the natural host of “B. hampsonii”. These trials are ongoing at the 
time of writing. Demonstration of a sufficiently low virulence in pigs will be critical to the success 
of P113 as a promising vaccine candidate, and further attenuation will likely be necessary. Based 
on previous experience with the lack of heterologous protection against different B. hyodysenteriae 
strains, other “B. hampsonii” strains should be used to challenge P113-vaccinated pigs in future 
studies (Joens et al., 1983).  
Further work identifying the “B. hampsonii” virulence determinants that have changed in 
P113 is still needed by detecting changes in the genome and putative virulence genes, such as tly 
cytolysins that have haemolytic activity and are linked to virulence (Muir et al., 1992, Keith et al., 
2016). However, the availability of these two strains with demonstrably different virulence in mice 
(and perhaps pigs) provide powerful resources for these studies. 
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4 General discussion 
4.1 Summary and limitations of the work 
4.1.1 Biochemical characterization alone is not sufficient for differentiation of “B. 
hampsonii” clades or discrimination from other Brachyspira spp. 
“B. hampsonii” is a novel Brachyspira taxon that has been demonstrated to cause 
mucohaemorrhagic disease in swine and is a contributor to the re-emergence mucohaemorrhagic 
disease (Chander et al., 2012). US isolates of both clades have been phenotypically and 
genotypically described (Chander et al., 2012), however Canadian isolates required further 
description to improve the knowledge of diagnostically informative characteristics.  
The results of this chapter describe the diagnostic biochemical traits of Western Canadian 
isolates of clade I and II “B. hampsonii”, indicating that biochemical traits cannot be relied upon 
for differentiation of clades due to variance of key biochemical traits in each clade. The chapter 
also includes descriptions of select biochemical traits (indole production, hippurate hydrolysis, α-
galactosidase, α-glucosidase, and β-glucosidase), β-haemolysis strength, spirochaete dimensions, 
and count of flagella per cell of representative Canadian clade I and II “B. hampsonii” strains 
relative to previous descriptions of other swine-associated Brachyspira species. The work also 
provided the first published electron micrographs of “B. hampsonii”. The results highlight that 
caution should be used when characterizing isolated Brachyspira spp. using phenotypic traits. The 
number of clade I isolates was small and was limited due to the apparent bias of more clade II “B. 
hampsonii” being present in Canada, and their corresponding rareness in our culture collection. 
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An additional constraint was that isolates were selected to be as epidemiologically independent as 
possible. Western Canadian swine production is dominated by a few large, interconnected systems, 
which limited the “independence” of many of the available clinical isolates.  However, even the 
small number of isolates was sufficient to indicate that there is variance in the diagnostic 
biochemical traits within clade I. Analysis of additional isolates will help with identification of 
other variances within and between “B. hampsonii” clades. Genotypic profiling of these isolates, 
with techniques such as RAPD, MLST, or whole genome sequencing would help describe genetic 
variation among clinical “B. hampsonii” isolates, which was addressed only by nox sequence 
comparison in our study to differentiate the two clades. 
 
4.1.2 In vitro attenuation produced a laboratory adapted and partially attenuated “B. 
hampsonii” clade II strain 
Results described in Chapter 3 demonstrated that the serially passaged “B. hampsonii” 
strain (P113) has become laboratory adapted and partially attenuated. The results of the haemolysis 
assays and growth curves showed that P113 was better adapted to laboratory medium, with more 
rapid growth on BJ agar and in broth medium. Our results do not allow us to determine if there 
have been changes in haemolysis activity, due to the adaptation of P113 to laboratory medium, but 
this could be studied in more detail using the in vitro haemolysis assay described by Mahu et al. 
(2016) that evaluates the haemolytic capacity of supernatant (from filtered broth culture) on a red 
blood cell suspension. With this approach, the haemolytic activity could be expressed relative to 
cell number, eliminating the confounding factor of growth rate. 
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The virulence assessment in a murine model demonstrated the partial attenuation, based on 
the lower average faecal scores in P113-inoculated mice compared to P13 inoculated mice. 
However, despite the change in virulence, no difference between these strains was identified by 
the genomic profile and sequence comparisons done to date. The P13 and P113 whole genome 
sequences compared in Chapter 3 are not yet of sufficient quality for a greater depth of comparison, 
however the addition of more sequencing data from an alternate method (paired-end sequencing) 
and annotation of the resulting assembled genomes will permit detection of differences between 
the genomes.  
 
4.2 Discussion of future prospects 
The work described in Chapter 2 was focused on improving the information available about 
Western Canadian isolates and pointed to the variation in the biochemical traits of clinical isolates, 
which is important for differentiating “B. hampsonii” clinical isolates from other Brachyspira 
species. However, there are many other questions that remain unanswered about “B. hampsonii” 
due to the fastidiousness of Brachyspira and the existence of Brachyspira spp. in communities 
within swine. Improved diagnostic tools would facilitate surveillance to improve understanding of 
Brachyspira distribution and ecology and detection of Brachyspira in healthy herds, but tools such 
as ELISA have yet to be developed to detect “B. hampsonii” exposure and antigens specific to “B. 
hampsonii” still need to identified and assessed. Currently, amplification and sequencing of the 
nox gene, or species-specific PCR targeting this gene, remain the preferred methods for detection 
and identification of Brachsypira. 
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P113 was shown to be partially attenuated and laboratory adapted, although the specific 
changes in genes and/or expression that produced these observed changes have not yet been 
identified. The virulence determinants of Brachyspira spp. are still not clear and further work 
comparing virulent and attenuated strains, such as P113, could lead to detection of novel virulence-
linked targets to study. Ongoing experiments will reveal the virulence of P113 in pigs, and 
determine if exposure to an attenuated strain provides protection from future challenge. Further 
studies are still required to characterize the mucosal immune response in swine to “B. hampsonii”, 
to better understand the effect of P113 as a vaccine and the immune response after challenge. 
Further studies in swine models are also needed to determine whether heterologous protection is 
possible against other “B. hampsonii” isolates and to characterize the immune response after 
exposure of pigs to P113. Ultimately, the success of a live attenuated vaccine depends upon 
sufficient reduction of virulence coupled with stimulation of a protective immune response against 
a sufficient range of pathogen strains. The work described in Chapter 3 represents some important 
first steps toward this goal.  
Future studies focused on “B. hampsonii” will improve diagnostics, prevention of disease, 
help with understanding the virulence of “B. hampsonii” and may provide clues about other swine-
virulent Brachyspira species. 
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